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Doth the ploughman plough all day to sow? Is he all day opening and breaking the clods of his land? 
Doth he not, when he hath levelled the face thereof, cast abroad dill, and scatter cummin, and set the 
wheat in rows, and the barley in an appointed place, and the rye in its border? 
His God doth instruct him in his discretion, he doth teach him. 
Isaiah chapter 28, verses 24 to 26, the Bible 

Opportunity (place) + time (seed) + patience (rain and sun) = Great Harvest 
 
  
ABSTRACT              ENGLISH 
Preservation of independence has been reported to be highly desired by older adults, even more than 
longevity. However, subclinical cardiovascular pathology can threaten a healthy older adult’s 
maintenance of physical function. Therefore, the aim of this thesis was to investigate the role and 
potential neuropathological mechanisms of cardiovascular disease-related risk factors in the 
development of physical limitation and disability in older adults. Data were taken from the Swedish 
National study on Aging and Care in Kungsholmen (SNAC-K) for the initial three studies and from the 
embedded SNAC-K MRI sub-study for the final study. 
Study I. Over six years of follow-up, of the 1971 persons free of disability in activities of daily living 
(ADL) at baseline, 119 (6.0%) persons developed ADL-disability. Limitation in both the one-leg 
balance stand (<5 sec.) and walking speed (<0.8 m/s) tests at baseline were associated with increased 
risk of future ADL-disability, but having both simultaneously showed a 10-fold higher likelihood of 
future ADL-disability. 
Study II. In a sample free of cardiovascular diseases (CVDs) and physical limitation at baseline 
(n=1441), a greater cardiovascular risk burden, defined by the Framingham general cardiovascular risk 
score (FRS), was associated with increased risk of walking speed limitation over nine years of follow-
up, but only in the younger-old adults (60-72 years old), not in the older-old (≥78 years old) (Hazard 
Ratio [HR] 1.09, 95% confidence interval [CI] 1.02–1.17; HR 0.98, 95% CI 0.92–1.03, respectively). 
Moreover, the FRS was not associated with future balance performance or muscle strength. 
Study III. In the sample free of CVD and ADL-disability at baseline (n=1756), among the younger-old 
adults, physical inactivity (HR 4.10, 95% CI 1.22-13.76), diabetes (HR 5.61, 95% CI 1.17-26.82), and 
high C-reactive protein (HR 95% 2.78, 95% CI 1.07-7.22) were associated with disability over nine 
years of follow-up. Among the older-old (≥78 years old), only physical inactivity was associated with 
greater risk of ADL-disability (HR 1.99, 95% CI 1.36-2.93), and walking speed modified this 
association, such that being physically inactive and having walking speed limitation, concomitantly, 
showed an even higher risk of ADL-disability.  
Study IV. A faster average annual decline in walking speed over nine years of follow-up, in older adults 
free of walking speed limitation at baseline (n=331), was observed for those with greater volumes of 
white matter hyperintensities (WMH) at baseline, or having a higher burden of brain abnormalities 
(WMH+lacunes+ perivascular spaces). 
Conclusion. Cardiovascular risk factors increase the risk of future physical limitation and disability, 
and brain abnormalities explain part of the underlying pathology driving the decline in physical 
function. However, risk profiles may differ between age groups of older adults, which suggests that 
interventions targeting decreasing cardiovascular risk may be more beneficial among younger-old 
adults, while older-old may benefit more from the maintenance of physical function. 
Key words: physical performance, disability, activities of daily living, chronic disease, cognitive 
function, Framingham general cardiovascular risk score, physical function, cardiovascular disease, risk 
factors, ICF, cerebral small vessel disease, walking speed, magnetic resonance imaging (MRI).  
  
SAMMANFATTNING           SVENSKA 
Att behålla sin självständighet är viktigare för äldre personer än att leva ett långt liv. Men, subklinisk 
kardiovaskulär patologi kan försämra en frisk äldre persons möjlighet att bibehålla sina fysiska 
funktioner. Därför var målet med denna avhandling att studera rollen, och potentiella neuropatologiska 
mekanismer, av kardiovaskulära sjukdomsrelaterade riskfaktorer i utvecklingen av försämrad fysisk 
funktion och nedsättning i aktiviteter i dagliga livet (ADL) hos äldre personer. Data från Swedish 
National study on Aging and Care in Kungsholmen (SNAC-K) användes för de första tre studierna och 
SNAC-K MRI substudie användes för den sista studien i avhandlingen. 
Studie I. Bland personer utan funktionsnedsättning i ADL vid den initiala bedömningen i början av 
SNAC-K studien (baslinje n=1971), utvecklade 119 (6,0%) personer funktionsnedsättning i ADL över 
en uppföljningsperiod på sex år. Funktionshinder i både balans (enbensstående <5 sek) och 
gånghastighet (<0.8 m/s) testat vid baslinje var associerat med ökad risk för framtida 
funktionsnedsättning i ADL, och att ha båda samtidigt visade en 10 gånger större risk för framtida 
funktionsnedsättning.  
Studie II. Bland personer utan kardiovaskulära sjukdomar och funktionshinder vid baseline (n=1441) 
var en ökning av kardiovaskulär risk enligt Framingham general cardiovascular risk score (FRS) 
associerat med en större risk av försämrad gånghastighet över nio års uppföljning, men bara bland de 
yngre-äldre (60-72 år) (Hazard Ratio [HR] 1.09, 95% konfidens intervall [CI] 1.02–1.17), inte bland 
äldre-äldre (≥ 78 år) (HR 0.98, 95% CI 0.92–1.03). FRS var inte relaterat till en framtida balansförmåga 
eller muskelstyrka. 
Studie III. Bland personer utan kardiovaskulära sjukdomar och funktionsnedsättningar i ADL vid 
baseline (n=1756), var fysisk inaktivitet (HR 4.10, 95% CI 1.22-13.76), diabetes (HR 5.61, 95% CI 
1.17-26.82) och hög C-reactive protein (HR 2.78, 95% CI 1.07-7.22)  associerat med 
funktionsnedsättning i ADL över en uppföljning på nio år bland de yngre-äldre. Emellertid, bland äldre-
äldre var enbart fysisk inaktivitet associerat med en högre risk för att utveckla ADL-
funktionsnedsättning (HR 1.99, 95% CI 1.36-2.93), samt att en kombination av inaktivitet och en 
långsam gånghastighet visade en ännu högre risk för att utveckla funktionsnedsättning i ADL. 
Studie IV. Äldre personer utan funktionshinder i gånghastighet vid baslinje (n=331) som hade en större 
volym av hyperintensiteter i vit hjärnsubstans (WMH) utvecklade en snabbare genomsnittlig försämring 
i gånghastighet över nio år. En högre börda av hjärnabnormaliteter (WMH, lacunes, perivaskulära 
spatier) vid baslinje gav samma resultat. 
Slutsatser. Kardiovaskulära riskfaktorer ökar risken av försämring i fysiska funktioner och 
funktionsnedsättning i ADL. Hjärnabnormaliteter förklarar delvis den underliggande patologi som 
driver försämringen i fysiska funktioner. Men riskprofiler skiljer sig mellan åldersgrupper bland äldre 
personer, således borde interventioner som syftar till att minska kardiovaskulär risk riktas mot den 
yngre-äldre befolkningen, medan interventioner med syfte att bevara god fysisk funktion skulle kunna 
göra mer nytta för de äldre-äldre. 
Nykelord. Fysisk prestationsförmåga, funktionsnedsättning, aktiviteter i dagliga livet, kroniska 
sjukdomar, kognitiv funktion, Framingham general cardiovascular risk score, fysisk funktion, 
kardiovaskulära sjukdomar, riskfaktorer, ICF, hjärn-kärlsjukdomar, cerebrala mikroangiopatier, 
gånghastighet, magnetisk resonanstomografi. 
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1 INTRODUCTION  
1.1 POPULATION AGING AND DISABILITY 
The World Health Organization (WHO) estimated that in 2010, 524 million people, making up 
8% of the world’s population, were aged 65 years and older. By 2050 this number is expected 
to triple to 1.5 billion, representing 16% of the global population, with the majority living in 
developed countries (1,2). Those 80 years and older are the fastest growing group, making up 
1% of the global population, and are expected to reach 4.1% in 2050. However, in Sweden the 
population of those 80 years and older has already reached over 5% (3). Life expectancy and 
the aging population during the 20th century is continuing to rise into the 21st century. From 
2002 to 2014, life expectancy has increased from 17.8 years to 20 years among those 65 years 
old in 27 European Union (EU) countries, and is expected to continue to grow rapidly in 
developed countries (4). 
Figure 1. Proportion of adults with limitation in at least one of the five activities of daily living aged 65-
74 and aged 75 years or older, by country. SHARE, Survey of Health, Ageing and Retirement in 
Europe; SAGE, Study on global AGEing and adult health. Source: World Health Organization (5). 
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These demographic transitions will result in a tremendous number of older adults being 
dependent on others for their personal care needs. Independent management of basic daily care 
activities, as long as possible, in older adults will help in the maintenance of a good quality of 
life, and deter burdens on families, thus decreasing societal health care costs (6).  These 
fundamental basic or self-care activities of daily living (ADL) include: feeding, dressing, 
bathing or showering, toileting, transferring from bed and chair, and incontinence. However, 
incontinence is often suggested to be a reflection of organ dysfunction rather than a physical 
function impairment (7), thus it is usually excluded as an ADL limitation in many studies. The 
basic ADL scale was originally defined by the geriatrician Dr. Sidney Katz in 1963, to aid 
physicians in tracking the illness and function of patients, in order to provide appropriate care 
needs, and develop specific treatments. The use of the ADL scale continues today as a primary 
assessment of disability in older persons (8). 
Figure 1 illustrates the age differences in the prevalence of ADL-disability across different 
countries (5). There is a clear variation across the countries in regards to the prevalence of 
ADL-disability. Also, there is a significantly greater percentage of people needing care in at 
least one activity in those 75 years old and above than those 65 to 74 years old. Different 
population-based studies have reported the incidence of disability, ranging from 4.9-47.0% (9-
17). Specifically, it was reported in a Swedish population of adults 78 years and older that the 
incidence of ADL-disability was 10.6% after three years, and 28.1% after six years (18). 
Similarly, the Rotterdam study (age 55+) reported an incidence of 26.7% after six years of 
follow-up (15), whereas, an Italian cohort of adults 65 years and older, estimated disability 
incidence to be 7.3% after three years (19).   
Temporal trends 
Trends of increasing prevalence rates of disability among older adults have been reported in 
some studies (20-23). For example, the Spanish National Health Survey reported that the 
probability of disability has increased by 13% from 2000 to 2006 in 21 058 persons 64 years 
and older (24). On the contrary, reductions or stability in disability prevalence have been 
detected in other population-based studies (24-27). A Swedish study reported that over the past 
two decades the prevalence and incidence of ADL-disability has stayed stable, with a tendency 
towards a slow decrease (28). A downward trend in disability has also been observed in other 
countries, such as in Japan (25), China (29), and USA (25,26,30). In summary, the trend for 
disability is difficult to predict and little is known about its course at the end of life. For 
example, it is suggested that the trend is mostly mixed, with both improvement and worsening 
being reported (31,32). Nevertheless, considering the rapid rise in the proportion of persons 
aged 65 years and older, and especially those 85+ years, the total number of people with 
disability will definitively increase in the future. Thus, research should strive towards gaining 
a deeper comprehension into the underlying pathways describing loss of physical function, 
with the aim of pin-pointing meaningful moments of intervention, and identifying specific and 
modifiable factors in order to prevent or delay the onset of disability.  
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1.2 PHYSICAL LIMITATION AND DISABILITY 
A key method in reducing the healthcare costs and helping older persons maintain 
independence into more advanced old age is through preservation of physical function. It has 
been estimated that at least half of end-stage disability is due to a progressive functional decline, 
while the other part results from acute clinical events (33). Decline in physical function, 
characterized by poor physical performance, is a prodromal period of disability (34), therefore, 
an ideal window of opportunity for the implementation of interventions to help older adults 
remain functionally independent longer.  
Conceptually, this project has been framed around the WHO’s International Classification of 
Functioning, Disability and Health (ICF) model, which was developed in 2001 to illustrate 
human function and the dynamic play between constructs (Figure 2)  (35,36). The ICF model 
will be used as a framework, providing a compound view of health without any assumptions 
on causality. Models of disability have been developed in order to help clarify the underlying 
processes that may lead to disability and to identify points of prevention and rehabilitation. 
Disability is not explicitly defined in the ICF model, but for this project it has been defined in 
accordance to the gerontological literature as dependence in activities of daily living (7,37) and 
has been categorized in the ICF model’s domain of “activity”. Particularly, for this project I 
have focused more on the medical and biological perspective of aging, proposing an age-related 
progressive deterioration of physical function (38). Using this perspective of the universal ICF 
model, we can understand the risk factors and underlying pathological processes (ICF domains 
of “health condition” and “body functions”) leading to disability. Physical limitations are 
classified as “body functions” in the ICF model and are considered as detached from a situation 
context (e.g. walking speed, balance) and disability as a situational variable (e.g. dependence 
in dressing, bathing, and feeding). Using this definition, disability is the result of a progressive 
decline in an individual’s capacity due to a synergistic effect between health conditions and 
contextual factors (35).  This supports the idea that poor physical performance may indicate 
intermediary stages from exposures to risk factors, through pathology/impairments to the onset 
and progression of disability.  
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Figure 2. International Classification of Functioning, Disability, and Health (ICF) model proposed by 
the World Health Organization) (36). Perforated circles represent areas focused on in this thesis. 
 
Physical performance tests (e.g. walking speed, balance, chair stand) provide pragmatic, 
appealing, valid, sensitive, and objective perspectives of physical function, owing to their 
minor influence from culture, language, and education (39). Also, these tests have low 
administration burden, therefore ideal for clinical and epidemiological settings as part of the 
geriatric assessment. These standardized measures can characterize different gradients of 
physical function and demonstrate strong predictability of future health status and adverse 
outcomes, such as nursing home admission and mortality, in clinical and epidemiological 
studies (40-44). In nondisabled persons, and even in high functioning individuals, physical 
performance assessments are able to discriminate between quite high functioning individuals 
(45,46). Furthermore, these tests may also predict disability, with the most recent studies 
summarized in Table 1. Walking speed has been most often investigated in relation to 
disability, with the other physical functions being neglected. Investigation into the other 
physical functions can offer more information regarding the different levels of physical 
function. Consequently, greater understanding can be gained into the temporal order of 
physical function loss and their predictability of future disability. Yet, further investigation is 
required, particularly in regards to mobility.  
 
Lower extremity function limitation 
Limitations in lower extremity function, such as mobility, is suggested to indicate a reduced 
reserve capacity early in the pathways to disability, increasing vulnerability (34). Aging is 
overall associated with a slowing of movement and diminished lower extremity function (47), 
yet in humans, locomotion is involved in most activities one must undertake every day to 
maintain independence and a good quality of life. Therefore, measures of mobility can provide 
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insight into health and function in aging and the disease progression. For instance, mobility 
limitation has also been shown to be associated with cognitive impairment (48,49). Within the 
mobility measures, a progression of decline has been suggested, where balance deteriorates 
prior to walking speed (50). The walking speed test has been demonstrated to be the most 
predictive of disability even in high-functioning older adults (51) and in the older-old (52). Yet, 
the hierarchical order in which each physical function declines and the extent of their predictive 
value has been rarely examined. This understanding might give a more accurate picture of the 
intermediate stages of disability loss and understanding of the different tests’ properties. 
Investigation into mobility levels, including walking speed and balance, plus their risk 
differences, are reasonable starting points as they are also central components of physical 
performance batteries (e.g. Short Physical Performance Battery, SPPB) and comprise more 
broad lower extremity tests (e.g. Timed Up and Go).  
Walking speed  
Walking is a fundamental ability of daily human function and to maintain independence. The 
walking speed test is a known robust measure of physical function, and limitation in this test 
can predict several adverse outcomes, such as cognitive impairment, institutionalization, falls, 
and mortality (40,43,53), and is ubiquitous among the older population. Furthermore, walking 
speed limitation has also been demonstrated in several studies as an indicator of future 
disability (11,14,51,54-59). Guralnik et al. showed that measuring walking speed alone was 
nearly as predictive as performing a full battery of performance tests (i.e. chair stand, walking 
speed, grip strength, and balance) in assessing subsequent disability (51). Contrarily, one study 
found the walking speed test to be inferior to a full battery in predicting disability over three 
years in adults 65 years and older (19). Yet, most studies have exhibited walking speed’s 
superiority. For example, a pooled analysis of seven different cohorts demonstrated walking 
speed’s ability to predict incident disability in bathing or dressing over three years in 27 220 
older adults 65 years of age and older (60). Walking speed has been named the 6th vital sign, 
due to its capacity to indicate health status, function, and future adverse outcomes, even in the 
absence of overt conditions (40,43,47,61). Of note, one study found that walking speed was a 
more sensitive predictor of disability in adults ≥75 years of age than those between 65 and 75 
years of age (14), suggesting that there may be variations by age. 
Walking speed is not only a robust marker, but also an attractive tool for utilization in both 
research and clinical settings, as it is easy to administer and requires little equipment. The 
distances usually performed (6 m or 4 m) are feasible in both settings (19,62), and avoids lower 
limb exhaustion and reduces in-test balance variations if done at a usual pace (62). Hence, the 
test is one of the most plausible to be performed in a geriatric assessment. Furthermore, 
clinically, the inherent biological phenomenon of walking speed in attesting disease, function, 
and the “vitality of life”, reflects its robustness in exposing concealed conditions of organ 
systems (62). This should be a call to clinicians to examine beyond the walking speed test as 
only a measure of physical function, but also as an indicator of other potential health conditions, 
such as cardiovascular disease (CVD). 
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Balance 
Balance also plays an important role in human gait. While moving, balance involves 
maintaining postural stability while keeping the center of mass over the center of pressure. In 
normal human gait there is a point of single stability, requiring input from physiological 
systems related to balance capabilities. With an increase in age there are also coinciding 
declines in visual, vestibular, and proprioceptive systems, which are all highly related to 
postural stability. However, balance in association with the risk of developing disability has 
not been studied independently (14,16,57,63), but instead combined in a score with other 
physical performance tests (14,16,19,51,64), neglecting a full understanding of the role of 
balance in relation to other measures. However, studies have been generally consistent in 
showing an association between poor lower balance performance and greater risk of disability. 
Particularly, the simple one-leg balance stand test (65) has been shown to be a good detector 
of older people at increased risk for future physical dysfunction (66,67), and can discriminate 
between high-functioning individuals (46).  
Impairments in balance performance have been suggested to precede a decline in walking 
speed. This may be due to the sensory systems, such as vestibular and proprioceptive, declining 
early in the aging process, thus balance tends to demonstrate lower predictive power of 
disability than walking speed (14,52). Yet, two studies have shown the contrary, reporting 
balance to be of higher predictive power than walking speed (14,16). The reasons for these 
conflicting results are mainly due to the assessment tools used (16) and age differences (14). 
Nevertheless, balance is a plausible early indicator in the functional decline and progression to 
disability, but its position in the decline of physical function and predictive power are unclear. 
 
Muscle strength 
With advancing age comes also the reduction in muscle mass and strength (68). Lower 
extremity muscle strength in clinical and epidemiological settings is often measured with the 
five times sit-to-stand chair stand test. The chair stand test employs the participant to move 
from a sitting to standing position without the use of their arms as fast as possible. Although, 
this test incorporates various muscle groups (e.g. gluteus maximus and tibialis anterior) and 
physical abilities (e.g. balance, speed, and power) (69,70), it is mainly a test of quadricep 
muscular strength for knee extension. Thus, impairment in the chair stand test has been 
correlated with sarcopenia – the age-related loss of muscle mass and strength, which can in 
turn increase the risk of disability (71). The task of going from bed to chair as part of the ADL, 
exemplifies the requirement of lower extremity muscular strength. Specifically, muscle groups 
of the lower limbs mainly perform concentric motions where a sufficient range of motion of 
the joints and power are required to fulfill the task. With increased velocity there is increased 
torque at the joints, particularly the hip, knee, and ankle. Thus, any limitation in the lower limb 
may affect performance on the chair stand test (72).   
Poor performance on the chair stand test has also been shown to predict mortality in older adults 
(42), and injurious falls (73), but has been little studied with regards to other health outcomes. 
More frequently it has been included in a composite score along with walking speed and 
balance, such as the SPPB (51,74). These few studies, nevertheless did show the chair stand 
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test to predict disability (51,57,74,75). As well, one review reported chair stand test to be a 
significant predictor of disability (76). One study of Japanese older women found no difference 
in chair stand time for women who developed ADL-disability than those who did not (77). 
Additionally, Guralnik et al. showed that among adults 70 years and older limitation on the 
chair stand test predicted ADL-disability after four years (RR 4.1, 95% CI 2.3-7.2) (52). 
It has been shown that the SPPB (including walking speed, balance, and  chair stand) is 
associated with incident disability independent of muscle mass (64). Indeed, reduced muscle 
strength is more associated with worse functional capacity than muscle mass (78).  However, 
slow walking speed and poor balance have been demonstrated to be more powerful predictors 
of disability than muscle strength (79). Therefore, it is essential to deconstruct the roles of 
different physical function measures and their related risk factors on future disability. 
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Table 1. A summary of major population-based longitudinal studies of various physical performance measures in predicting incident disability in activities of daily living. 
Study, Year, 
Country 
Study population N 
Age 
(years) 
Follow-up 
Time (years) 
Measures/tests Main findings 
Minneci et al. 2015 
(19), Italy 
The Insufficienza Cardiaca negli 
Anziani Residenti a Dicomano 
Study 
561 65+ 3 SPPB, walking speed, and hand-grip 
strength 
Incidence of disability was 7.3%. 
All predicted disability 
Legrand et al. 
2014 (64), Belgium 
BELFRAIL study (BFC80+) 
 
421 80+ 2.8 SPPB Multi-adjusted OR of 0.49 (95% CI 
0.31–0.78) 
Idland et al. 2013 
(12), Norway 
 
A community cohort of women  113  75-92 9 Functional reach, step climbing, and 
walking speed 
25.7% disabled at follow-up. 
Walking speed was the strongest 
predictor (OR 0.40, 95% CI 0.02-
0.69) 
Cawthon et al. 
2011 (80), USA 
Health, Aging and Body 
Composition Study  
2484 70-80 6 Strength (knee extension, grip strength), 
walking speed, and chair stands 
Adiposity and physical performance, 
but not strength were associated with 
disability 
Wennie Huang et 
al. 2010 (16), USA 
 
Community cohort study 110 65+ 2.5 SPPB, walking speed, Berg balance 
scale, grip strength, and timed up and 
go 
Balance was the strongest predictor 
Rosano et al. 2008 
(58), USA 
Cardiovascular Health Study 3156 65+ Median 8.4 Walking speed, and 
DSST 
Lower DSST score and slower gait 
individually or combined were 
significantly associated with greater 
risk of incident disability 
Onder et al. 2005 
(57), USA 
Women’s Health and Aging 
Study  
884 65+ 3 Walking speed, balance, chair stands, 
putting on a blouse, Purdue pegboard 
test, and grip strength, and summary 
performance scores 
All except grip strength predicted 
ADL-disability. Walking speed and 
summary performance scores 
showed the greatest predictability 
Guralnik et al. 
2000 (51), USA 
EPESE and Hispanic EPESE 4588, 
1946 
65+ 6 Balance, walking speed, chair stand, 
and summary performance score 
Summary performance score or 
walking speed alone predicted 
disability 
Shinkai et al. 2000 
(14), Japan 
Tokyo Metropolitan Institute of 
Gerontology Longitudinal 
Interdisciplinary Study of Ageing  
949 65+ 6 Walking speed, balance, and hand-grip All predicted disability, but walking 
speed was most sensitive 
*Only bathing and dressing in activities of daily living (ADLs) as outcome; SPPB: short physical performance battery; DSST: digit symbol substitution test; EPESE: Established 
Populations for the Epidemiologic Study of the Elderly; DXA: dual X-ray absorptiometry; CT: computed tomography; OR: odds ratio; RR: relative risk; CI: confidence interval. 
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1.3 CARDIOVASCULAR RISK FACTORS  
Cardiovascular disease (CVD) is one of leading causes of death worldwide, contributing to 
46.2% of all deaths in 2012 (81). Subclinical cardiovascular conditions, which may exist in 
younger and middle aged populations long before its clinical manifestation, can increase the 
risk of a future CVD event (82). The underlying process that results in CVD is atherosclerosis. 
This complex process can occur over several years or even decades, where fatty material and 
cholesterol are deposited inside the lumen of arteries. These deposits, known as plaques, disrupt 
the inner surface of the vessels, making it harder for blood to flow through. Blood clots 
rupturing in the coronary artery can lead to a cardiovascular event, like a heart attack, whereas 
in the brain can lead to a stroke (83). The factors that promote the process of atherosclerosis, 
defined by the WHO, and included in this project, are known as cardiovascular risk factors 
(CRFs), and include: 1) behavioural risk factors, including smoking, physical inactivity, 
harmful use of alcohol; and 2) metabolic risk factors, including raised blood pressure 
(hypertension), high body mass index (BMI), diabetes, and raised blood lipids (e.g. cholesterol) 
(83).  
These CRFs are estimated to contribute to 90.4% of the population attributable risk (PAR) for 
myocardial infarction (84), with high total cholesterol, smoking, hypertension, obesity, and 
diabetes contributing 80% of the PAR. Particularly, it has been found previously in the SNAC-
K population (which was utilized for this doctoral project) that the prevalence of some CRFs 
increased with age (e.g. hypertension and diabetes), while others decreased with age (e.g. 
obesity, high total cholesterol) (85). Therefore, these factors are feasible targets for prevention 
of CVD (84), but their risks may differ by age. A large percentage of CVDs can be avoided 
through improvements of cardiovascular risk profiles through interventions reducing  
behavioural and metabolic risk factors as defined by the WHO (83). These CRFs not only 
increase the risk of CVD, but also the risk of cognitive impairment in older adults (86). Thus, 
identification of at-risk persons can allow for subsequent implementation of appropriate 
procedures, according to their CRF profiles, to reduce the risk of future adverse health events. 
1.4 CRFS, PHYSICAL LIMITATION, AND DISABILITY 
CVD has been shown to contribute to a loss in physical function (34), and it has been estimated 
that over 25% of disability is attributable to CVD in older adults (87).  The effect of CRFs on 
increasing the risk of CVD is well-established, while the association with future physical 
limitation and disability still requires some investigation, especially concerning individual and 
aggregated CRFs, and age variations. The subclinical atherosclerotic process may be indicated 
through diminishment in physical abilities in the absence of CVD, manifesting as deficiencies 
on various physical performance tests. Tables 2 and 3 summarize the longitudinal population-
based studies investigating the association between individual and combined CRFs and 
physical limitation or disability in older adults. Most of these investigations have explored the 
association between CRFs and walking speed or test batteries, ignoring other physical functions 
and disability. A systematic review has summarized the studies examining the association 
between CRFs and specifically walking speed in noninstitutionalized adults 60 years and older 
(62). They identified eight prospective studies, showing significant associations between CRFs 
and impaired walking speed, but there is much variation in the risk due to heterogeneity 
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between study protocols for the testing of walking speed. Furthermore, some CRFs are given 
more attention than others in association with physical limitation, such as physical activity, 
hypertension, and obesity. 
 
Behavioural risk factors 
Physical activity 
Physical inactivity is a well-known risk factor for CVD and even more so in older adults. It is 
recommended by the WHO that older adults perform 150 minutes of moderate-intensity 
physical activity per week or 75 minutes of vigorous-intensity physical activity over a week or 
an equivalent combination. They are also recommended to perform physical activity to enhance 
balance and prevent falls, and perform muscle-strengthening activities two or more days a week 
(88). It is recognized that an active lifestyle is profitable in reducing the risk of morbidity and 
all-cause mortality. There is also a substantial economic benefit from leading an active life on 
a societal level. Globally in 2010, it has been estimated that 55% and 18% of older adults and 
younger adults, respectively, were insufficiently active (89).  In Sweden it was reported that 
28.7% of adults 18 years and older perform insufficient physical activity, according to the 
WHO recommendations (90). In the US, it has been estimated that 5.6 billion US dollars could 
have been saved from coronary heart disease if just 10% of US adults began a regular walking 
program. Yet, despite the awareness of the high costs and reduction in CVD risk from physical 
activity, the prevalence of physical inactivity remains high (91), and is on the rise, even more 
so among older adults.  
The benefits of physical activity on improving physical function in population-based studies 
are well-known (92-96), although fewer studies demonstrated the positive effects on basic self-
care ADL (92,97-99). However, these studies have consistently shown a beneficial effect of 
physical activity on future functional ability. Likewise, most studies have not been conducted 
in relatively healthy older populations (i.e. excluding those with chronic conditions, especially 
CVD). Randomized controlled trials have also revealed promising results of exercise 
interventions on improving physical function, but mainly in frail older adults (100,101). 
Research has shown that exercise, even if initiated late in life can have protective effects against 
disability and can possibly postpone it (102). In both a Mexican and American population-
based study of adults a beneficial effect of physical activity on ADL-disability was 
demonstrated after two years of follow-up (102). In a cohort study of adults from 39 to 63 years 
of age, over 8.8 years of follow-up, showed that a physically active mid-life is important to 
maintain physical function in later life (103). Also, another study including American and 
British populations found that higher levels of physical activity in adults between 50 and 69 
years of age were associated with lower risk of mobility impairment over six years of follow-
up (95). However, not many studies have investigated this association in older-old adults (e.g., 
80+ years). One meta-analysis of longitudinal studies of adults 50 years and older, examining 
the association between physical activity and incident disability (96), found that out of the nine 
studies, all but one showed a lower risk of disability in those who were physically active 
compared to those who were inactive. This was evident in both those <74 years old and those 
≥75 years and older.  
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Alcohol consumption  
Alcohol consumption in association with physical function and disability is less established. In 
the Whitehall II cohort study, they found that nonmoderate alcohol consumption (none/ 
occasional or heavy) was associated with slower walking speed over 17 years of follow-up 
(104). Also, in the EPESE cohort, adults 65 years and older that did not consume alcohol 
compared to those who had a small to moderate intake had worse mobility after four years of 
follow-up (105). However, the contrary has also been shown in other studies finding no 
association with mobility limitation (106). Studies looking at other tests of physical 
performance than only walking speed, or distinguishing between them are generally lacking. 
An American study found that moderate alcohol consumption (five or more drinks per year 
without alcohol problems) was associated with improved physical performance, however it 
was a combined battery of physical performance tests of which walking speed, chair stand, 
balance, and grip strength were incorporated (107). Never consuming alcohol has also been 
shown to be associated with incident disability compared to those who were moderate 
consumers (98). Whereas another study found that there was no association between any levels 
of alcohol consumption and disability over 12 years of follow-up (92). 
Smoking 
Smoking cessation can have tremendous beneficial effects on health and is one of the most 
effective preventive measures against CVD. However, very few previous studies have looked 
at functional consequences of smoking among older adult populations (108), and 
longitudinally. The few studies that have investigated this association, have found current 
smoking to be associated with walking speed limitation (104,105), or poor overall physical 
performance (107). Also, smoking has been found to be associated with disability 
(92,97,98,107), but one study has also demonstrated a non-significant association with 
disability (109). The prospective Whitehall II cohort study showed that smoking was associated 
with poor physical function performance, although a weak association over 17 years of follow-
up (104). The young- and middle-aged British 1946 Birth Cohort Study likewise found that 
greater smoking pack-years was related to reduced overall physical performance and poorer 
performance in balance and chair stand, even after controlling for other conditions (110). This 
too was observed in another study that exhibited a greater risk of losing mobility function after 
four years in adults 65 years and older who were current smokers (105). 
 
Cardio-metabolic risk factors 
Hypertension 
It is estimated that about 1 billion individuals experience hypertension globally, and about 7.1 
million deaths per year may be attributable to hypertension. Also, its prevalence increases with 
age, and the number of persons receiving hypertension treatment has increased considerably. 
Over half of adults between 60 and 69 years of age, and about three-fourths of adults 70 years 
and older experience hypertension (111). 
High blood pressure has also been suggested to demonstrate a J- or U-shaped relationship with 
mortality in older age, such that both high and low blood pressure are associated with greater 
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risk of mortality (112). It is suggested that low blood pressure may be an indicator or 
consequence of frailty, as blood pressure tends to decrease prior to a critical event, such as 
death (112,113).  
Hypertension has been found previously to be associated with a faster decline in physical 
function. In the Cardiovascular and Health Study including a cohort of adults 65 years and 
older, hypertension was associated with an accelerated decline in walking speed over 18 years 
of follow-up (114), independent of other risk factors in a well-functioning population. 
Similarly, in the Dijon Three-City study (115), and the Adult Changes of Thought Study (107), 
both found hypertension to be associated with incident slow walking speed over 3 to 18 years 
of follow-up. Yet, in the Health and Retirement Study of adults 65+, there was no association 
between hypertension and decreased walking speed over four years (106). Several studies have 
reported a rather consistent association between hypertension and a greater risk of disability 
(99,107,109,116). 
Obesity  
High BMI, particularly obesity, has been studied in relation to physical function and disability. 
Research has shown that two-thirds of adults, 60 years and older, are overweight and one-third 
are obese in the US (117). With aging there is a reduction in muscle mass, accompanied by an 
increase in fat mass. Higher fat mass has been previously shown to be associated with disability 
(118). Older adults who are obese have been found to experience disability in ADL about five 
years earlier and are twice as likely to develop physical limitation or disability (119). A review 
of longitudinal studies reported that together an accrual of adipose tissue with reduced skeletal 
muscle, impacts future development of functional impairments (120). Evidence suggests that 
obese older adults are characterized by having a lower strength to body mass ratio compared 
to their non-obese counterparts, predominantly for tasks that entail lower extremity strength, 
such as walking and rising from a chair (117). 
A review of 15 longitudinal studies reported a relationship between adiposity and declining 
mobility. The studies consistently found that obesity compromised walking, stair climbing, and 
getting up from a chair (120). Other studies have also shown a significant association between 
obesity and mobility or walking speed limitation (106,121-124). A study of Finnish middle-
age adults found that high BMI at baseline was associated with age- and sex-adjusted risk of 
walking speed limitation after 22 years (124). Correspondingly, several longitudinal studies 
examining the association between obesity and disability consistently showed an association 
between obesity and increased risk of disability (97,109,121,125,126). However, a U-shape or 
J-shape relationship has also been suggested between levels of BMI and the risk of disability 
(125), meaning that underweight may also be a risk factor for disability. Indeed, one study 
found that being underweight (<18.5 kg/m2) or obese (>30 kg/m2) were both associated with 
increased risk of disability) (127). 
Total cholesterol  
Cholesterol is a biological molecule that is essential for maintaining cell membrane stability, 
and is also important for hormone and vitamin synthesis (128). Cholesterol is also a main player 
in atherosclerosis. There is a paucity, but also an incongruity, of research on high total 
cholesterol in association with physical function and disability. The Longitudinal Aging Study 
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of Amsterdam found no association between total cholesterol and functional status over three 
years in men, but discovered a significant association in women (129). Whereas the 
Framingham Disability Study showed no association between total cholesterol in midlife and 
disability over 27 years (109). However, high total cholesterol has been examined as a 
component of clustered CRFs, where associations were found between reduced burden of 
CRFs and improved physical performance (130-132) or reduced risk of  disability (133,134). 
Diabetes  
Type II diabetes, hereafter termed diabetes, affects more than one in five older adults age 65 
years and older (117), and its prevalence is on the rise globally. Diabetes is one of the most 
often investigated CRFs in relation to functional outcomes. A meta-analysis of nine 
longitudinal studies found that diabetes is strongly associated with disability, defined as basic 
or instrumental activities of daily living, or mobility limitation, with follow-ups ranging from 
18 months to nine years (135). Four longitudinal studies in this meta-analysis that examined 
the risk of mobility limitation found that persons with diabetes were more likely to report 
physical limitation than those without diabetes. Only two studies were reported in the meta-
analysis to have looked at ADL-disability, showing an increased risk of disability in those with 
diabetes (135). Overall, this meta-analysis found a 50-80% increased risk of disability among 
persons with diabetes compared to those without. Furthermore, in the Study of Osteoporotic 
Fractures, over 12 years of follow-up, women with diabetes were twice as likely to become 
disabled as persons without diabetes. Interestingly, age differences were also observed. The 
association between diabetes and disability was strongest among women 65-69 years old, and 
diabetes was not associated with disability in women 80 years and older (136). The annual 
incidence of disability was about 10% among women with diabetes and about 5% among 
nondiabetics (136). Yet, despite the many studies showing an association between diabetes and 
poor physical performance, diabetes has also exhibited no association with slow walking speed 
over four years in the Health and Retirement study of adults 65 years and older (106). 
C-reactive protein (CRP)  
CRP is a marker of overall inflammation in the body. Although not originally included in the 
WHO’s list of CRFs, inflammatory factors have also been associated with functional status, 
particularly in the context of “inflammaging” (137). The US Einstein Aging Study suggested 
that elevated CRP levels were associated with decreased walking speed over two years in adults 
70 years and older (138), and the association was stronger in those without vascular diseases. 
Likewise, in the Health, Aging and Body Composition Study, the relative risk of subsequent 
mobility limitation associated with per standard deviation increase in CRP was 1.40 (95% CI 
1.18-1.68) over 30 months of follow-up (139). These findings remained after exclusion of those 
with baseline and incident cardiovascular events or hospitalizations. Yet, we also see that CRP 
is not associated with limitation in mobility over six years in older Italian adults (140). 
Correspondingly, another study found an association between CRP and disability cross-
sectionally, but not longitudinally (141). 
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Individual vs combined CRFs  
Most studies have investigated individual CRFs in association with functional outcomes, 
however, it is also important to look at the functional impact of their aggregation and severity, 
as older adults are more likely to experience multiple CRFs concomitantly. The need also to 
disentangle them helps to understand the specific relationships between each factor and the risk 
for adverse outcomes, for the development of more precise preventive strategies. Therefore, 
research that include both clustered and individual CRFs is important. However, very few 
studies have examined the concomitant effect of multiple CRFs, despite their prominent co-
occurrence in older persons, and in relation to a diversity of physical performance measures. A 
population-based cross-sectional study of older adults in Sweden, using the same population 
as in this thesis project, showed an increasing linear association between the number of CRFs 
and an increased likelihood of mobility limitation (142). In the Three City-Study, of adults 65 
years and older, an increasing number of unhealthy behaviours (i.e. physical inactivity, low 
fruit and vegetable consumption, smoking, and alcohol consumption) were associated with a 
greater risk for disability over 12 years of follow-up. Specifically, participants with three or 
more unhealthy behaviours had a 2.5-fold higher risk of disability (92). 
Some algorithms combining CRFs have been created, such as the Framingham general 
cardiovascular risk score (FRS) (143). The FRS was developed as part of the Framingham 
Study for predicting the risk of cardiovascular events and for identifying persons who are at 
risk, for early intervention (143). The FRS is a well-established risk score for predicting future 
cardiovascular events and cognitive decline (143,144), however, it has been mainly 
investigated in middle-aged and younger-old (age <75 years) populations in relation to physical 
impairment or disability. The English Longitudinal Study of Ageing showed that the FRS can 
predict frailty in older adults (145), and the Whitehall II cohort study demonstrated an 
association between trajectories of the FRS change over 16 years according to baseline physical 
function in a middle-aged population (130). Yet, there is generally a lack of information on the 
risk among older adult populations. 
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Table 2.  A summary of major longitudinal population-based studies on individual and clustered cardiovascular risk factors and physical function. 
Author, Year, 
Country 
Study Population 
Follow-up 
length 
Age 
(years) 
Cardiovascular risk factors 
Physical function outcome 
measures 
Main findings 
Individual cardiovascular risk factors 
Verghese 2016  
USA (106) 
Health and 
Retirement Study 
N=2306 
4 years 65+ 
Physical inactivity, alcohol, obesity, 
diabetes, hypertension 
 
Walking speed 
Physical inactivity predicted incident slow walking speed 
(adjusted RR=1.94; 95% CI 1.20-3.12. Alcohol consumption 
was not associated with incident walking speed limitation. 
Hypertension did not predict slow walking speed (RR=0.988; 
95% CI 0.71-1.39). Obesity predicted slow gait (RR=1.35; 
95% CI, 1.07-1.69). Diabetes did not predict slow walking 
speed (RR=1.16; 95% CI 0.86-1.56) 
Sabia 2014 
England (104) 
Whitehall II study 
N=5671 
17 years 
Mean 
49.1  
Current or recent smoking, 
nonmoderate alcohol consumption 
(abstinence or heavy), fruit and 
vegetable consumption less than 
twice per day, and physical 
inactivity 
Walking speed 
Physical inactivity, alcohol consumption, and smoking were 
associated with slower walking speed at follow-up. 
Koster 2008 
USA (94) 
Health, Aging and 
Body Composition 
study. 
N=2982 
6.5 years 70-79 
Physical activity 
 
Mobility limitation (difficulty walking 
one-quarter of a mile or climbing 10 
step) 
Low physical activity was associated with future mobility 
limitation. 
Lang 2007 
USA & 
England (95) 
The Health and 
Retirement Study 
(HRS) 
N=8702 
 
The English 
Longitudinal Study 
of Ageing (ELSA) 
N=1507 
HRS: 
Median 72 
months (IQR 
70–74 
months). 
ELSA: 
Median 73 
months 
(IQR69–77 
months). 
50-69 Physical inactivity 
HRS: self-reported mobility 
impairment. difficulty walking 
several blocks, climbing several 
flights of 
stairs, and climbing one flight of 
stairs 
 
ELSA: balance, chair stands, and 
grip 
strength 
In all BMI categories, those who reported 3 or more days of 
activity per week had a lower incidence of physical 
impairment than those who reported less activity 
Forrest 2006 
USA (93) 
Study of 
Osteoporotic 
Fractures (SOF) 
N=5178 
10 years 65+ 
Physical inactivity, smoking, 
diabetes, hypertension, obesity 
Walking speed and chair stand 
No association of physical activity with walking speed 
decline or chair stand decline performance. 
Higher weight and systolic blood pressure were associated 
with greater walking speed decline, as well as diabetes and 
smoking. Higher weight, smoking, and diabetes were 
associated with decline in chair stand performance. No 
association between physical activity or alcohol with either 
physical function. 
Wang 2002 
USA (107) 
Adult Changes in 
Thought (ACT) 
Study  
N=2578 
Mean 3.4 
years 
65+ 
Diabetes, hypertension, coronary 
heart disease, cerebrovascular 
diseases, osteoporosis, arthritis, 
cancer, low cognitive function, 
Walking speed, chair stand, 
standing balance, and grip strength 
Exercise (3 times or more per week) was associated with 
better physical performance. Smoking was associated with 
poor physical performance. Alcohol use (5 drinks or more 
per year without alcohol problems) was associated with 
better physical performance. Hypertension was associated 
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depression, smoking, alcohol use, 
and exercise 
with poor physical performance. Diabetes was associated 
with poor physical performance. 
Rosano 2011 
USA (114) 
Cardiovascular 
health study (CHS) 
N=2733 (724 with 
MRI) 
18 years 65+ Hypertension  Walking speed 
Recent hypertension, with uncontrolled blood pressure, and 
those who successfully controlled blood pressure had an 
accelerated decline in walking speed. 
Dumurgier 
2010 
France (115) 
Three City study 
N=3604 
(1590 did MRI) 
Mean 7 
years 
65-85 
Hypertension  
 
Walking speed 
People with hypertension had a faster decline in walking 
speed 
Artaud 2016 
France (121) 
Three city Dijon 
cohort study 
N=4007 
11 years 65-85 Obesity Walking speed Obese persons had a 45% faster walking speed decline.  
Stenholm 2010 
USA (123) 
Health, Aging and 
Body Composition 
Study 
N=2984 
6.5 years 70-79 Obesity 
Mobility limitation (difficulty walking 
1-quarter mile or climbing 10 steps) 
Obesity was associated with increased risk for mobility 
limitation. 
Stenholm 2007 
Finland (124) 
Mini-Finland 
Follow-up Survey 
N=840 
22 years 32–72 BMI 
Walking limitation (<1.2 m/s) or 
difficulty in walking 0.5 km 
High BMI was a predictor of walking limitation. 
Launer 1994 
USA (122) 
NHANES I 
N=1124 
8-16 years 
(for past 
BMI) 
2-5 (for 
current BMI) 
45-74 
BMI and weight change 
 
Mobility disability (walking across a 
room, climbing two steps, doing 
heavy chores, carrying a full bag of 
groceries, running errands, bending 
to the floor, or transferring from a 
car, bed, bath chair or toilet) 
High BMI was associated with increased risk of mobility 
disability. 
Schalk 2004 
The 
Netherlands 
(129) 
The Longitudinal 
Aging Study of 
Amsterdam 
3 years 55-85 
Serum albumin and total 
cholesterol   
Walking speed and putting on and 
taking off a cardigan 
No association between total cholesterol and functional 
status in men, but in women low cholesterol associated with 
decline in function. 
Vasunilashorn 
2013 
Italy (140) 
The Invecchiare in 
Chianti 
(InCHIANTI) 
N=1006 
6 years 65+ 
Eight markers of inflammation 
including C-reactive protein 
 
Walking speed 
C-reactive protein was not associated with incident walking 
limitation. Those with the highest scores of the inflammatory 
markers showed highest risk of mobility disability. 
Verghese 2012 
USA (138) 
Einstein Aging 
Study (EAS) 
N=624 
 Median 2 
years 
70+ C-reactive protein Walking speed 
High C-reactive protein was associated with greater risk of 
mobility limitation and the association was stronger in those 
without vascular diseases. 
Penninx 2004 
USA (139) 
Health, Aging and 
Body Composition 
Study 
N=2979 
30 months 70-79 C-reactive protein 
Difficulty or inability to walk one-
quarter of a mile or to climb 10 
steps 
C-reactive protein was associated with mobility limitation (RR 
1.40, 95% CI 1.18–1.68). 
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Clustered or multiple cardiovascular risk factors 
Jin 2017 
Italy (131) 
InChianti 
N=906 
9 years 65+ Life’s Simple Seven score Short physical performance battery Cardiovascular health behaviours were protective against 
poor physical function.  
Windham 2017 
USA (132) 
Atherosclerosis 
Risk in 
Communities 
(ARIC) study 
N=15 744 
25 years 45-64 Life’s Simple Seven score  
 
 
Short physical performance battery LS7 at mid-life was associated with a better SPPB score in 
late-life.  
Ideal glucose, smoking, blood pressure, BMI, and physical 
activity were most strongly associated with future physical 
function performance. 
Sabia 2014 
England (104) 
Whitehall II study 
N=5671 
17 years  Current or recent smoking, 
nonmoderate alcohol consumption, 
fruit and vegetable consumption 
less than twice per day, and 
physical inactivity 
Walking speed All risk factors were associated with a slower walking.  
 
Elbaz 2014 
England (130) 
Whitehall II cohort 
study 
N=5376 
16 years 35–55 Framingham general 
cardiovascular risk score 
Walking speed, 5 time chair stand; 
balance, grip strength, finger 
tapping 
Poor performance on walking speed, chair rises and balance 
were associated with a higher Framingham general 
cardiovascular risk score. 
LaCroix 1993 
USA (105) 
Established 
Populations for 
Epidemiologic 
Studies 
of the Elderly 
N=6981 
4 years 65+ Physical activity, alcohol, smoking, 
BMI 
 
Intact mobility (the ability to climb 
up and down stairs and walk a half 
mile) 
Current smoking, consuming alcohol, high BMI, and low 
physical activity were associated with increased risk of poor 
mobility. 
Reviews and/or meta-analysis of studies investigating various cardiovascular risk factors and physical functions as outcomes: Wong 2013 (diabetes) (146); Bianchi 2016 (diabetes) (147); Vincent 2010 
(Obesity) (120). 
Life’s Simple Seven score includes cardiovascular health factors: smoking, body mass index, physical activity, dietary intake, blood pressure, glucose, cholesterol. Framingham general cardiovascular risk 
score includes: High-density lipoprotein cholesterol, total cholesterol, systolic blood pressure, cigarette smoking, and diabetes. Short Physical Performance Battery includes: walking speed, chair stand, 
standing balance. 
LS7: Life’s Simple Seven; MRI: magnetic resonance imaging; RR: relative risk; CRP: C-reactive protein; BMI: body mass index. 
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Table 3. A summary of major longitudinal population-based studies on cardiovascular risk factors and disability in activities of daily living. 
Author, 
Year, 
Country 
Study Population 
Follow-
up 
length 
Age 
(years) 
Cardiovascular risk factors Disability outcome measures Main findings 
Dhamoon 
2017 
USA (141) 
Northern Manhattan 
Study 
N=2240 
Median 
13 years 
40+ C-reactive protein Barthel index 
High C-reactive protein was associated with higher 
baseline disability, but not with the change of 
disability over time. 
Koye 2017 
Australia 
(126) 
The Australian 
Diabetes, Obesity and 
Lifestyle (AusDiab) 
study 
N=2373 
12 years 60+ Diabetes and BMI ADL 
Diabetes was associated with higher odds of 
disability. BMI and other cardiometabolic factors 
explained this association. 
Artaud 2016 
France (121) 
Three-City Dijon Study 
N=4478 
11 years 
 
65-85 BMI  Mobility, IADL, ADL 
Obese persons had a faster decline in walking 
speed. 
Vu 2016 
USA (134) 
The Chicago Heart 
Association Detection 
Project in Industry 
N=6014 
32 years 
Mean 
43 
Life’s Simple Seven score IADL and ADL 
Having a low or moderate risk of CVD at younger 
age was associated with lower odds of disability in 
older age. 
Artaud 2016 
France (121) 
Three city Dijon cohort 
study 
N=4007 
11 years 65-85 
BMI 
 
IADL and ADL 
Obesity was associated with a higher risk of 
disability. 
Dhamoon 
2015 
USA (133) 
The Northern 
Manhattan Study 
-stroke-free 
N=3219 
Median 
13 years 
40+ Life’s Simple Seven score Barthel Index 
Higher cardiovascular health score was 
associated with higher Barthel Index score. 
Artaud 2013 
France (92) 
Three-City Study 
N=3982 
12 years 65+ 
Unhealthy behaviors (low/intermediate 
physical activity, consuming fruit and veggies 
less than once a day, current smoking/short 
term ex-smoking, never/former/heavy alcohol 
drinking) 
Mobility, IADL, ADL 
Physical activity, low fruit and vegetable 
consumption, and smoking were associated with 
increased hazard of disability, but not alcohol 
intake. Risk increased with the number of 
unhealthy behaviours. 
Chakravarty 
2012 
USA (97) 
University of 
Pennsylvania alumni 
N=2327 
15.6 
years 
 
60+ 
Low-, medium-, and high-risk based on 
overweight, smoking, and inactivity 
Health Assessment Questionnaire 
Disability Index (rising, dressing and 
grooming, hygiene, eating, walking, 
reach, grip, and routine household 
activities) 
Those with medium and high risk lifestyle factors 
had a higher risk of disability than the low risk 
group. 
Gerst 2011 
Mexico & 
USA (102) 
Mexican Health and 
Aging Study 
(MHAS) and the 
Health and Retirement 
Study (HRS) 
2 years 50+ Vigorous physical activity or exercise 
ADL 
 
Physical activity is protective for ADL disability. 
Those who exercise have a lower probability of 
transitioning to disability or death. 
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Liao 2011 
Taiwan (98) 
 
Taiwan Longitudinal 
Study in Aging 
N=3187 
14 years 60+ 
Not smoking, moderate alcohol consumption, 
regular exercise, and 
sleeping 6 to 8 hours per day 
 
ADL (bathing or walking) 
Healthy behavior was associated with lower 
hazard of disability. Increasing number of healthy 
behaviours showed decreasing likelihood of 
disability. 
Newman 
2009 
USA (99) 
Cardiovascular 
Health Study (CHS) 
N=1677 
13 years 77-102 
Hypertension, physical activity, CVD  
 
ADL 
Hypertension and physical inactivity was 
associated with incident ADL-disability. 
Al Snih 2007 
USA (127) 
Established 
Populations for 
Epidemiologic 
Studies of the Elderly 
(EPESE) 
N=12725 
7 years 65+ 
Obesity (BMI ≥30kg/m2) 
 
 
ADL 
Subjects with BMI<18.5 or ≥30 at baseline were 
more likely to experience disability during the 
follow-up period. 
Hajjar 2007 
USA (116) 
Charleston Heart 
Study 
N=999 
9 years 
Mean 
68.5 
Hypertension ≥140/90 or receiving anti-
hypertensive agents 
 
Nagi’s Congruency in Medical and 
Self-Assessment of Disability, the 
Rosow-Breslaw Scale and Katz’s 
ADL Scale 
Greater SBP increase was associated with greater 
decrease in physical function 
Hypertensive vs normotensive showed greater 
decline in function, and  a greater risk of 
developing disability. 
Gregg 2002 
USA (136) 
Women from the 
Study of Osteoporotic 
Fractures 
N=8344 
12 years ≥65 
Diabetes 
 
Walking 0.25 mile, climbing 10 
steps, performing household chores, 
shopping, and cooking meals 
Diabetes was associated with a greater risk of any 
of the limitations. 
Wang 2002 
USA (107) 
Adult Changes in 
Thought (ACT) Study  
N=1873 
Mean 3.4 
years 
65+ 
Diabetes, hypertension, coronary heart 
disease, cerebrovascular diseases, 
osteoporosis, arthritis, cancer, low cognitive 
function, depression, and smoking 
 
 
IADL and ADL 
Diabetes, hypertension, and smoking were 
associated with more ADL limitation. Alcohol use 
(5 drinks or more per year without alcohol 
problems) and exercise (3 times or more per 
week) was associated with less ADL limitation. 
Sarkisian 
2000 
USA (148) 
The Study of 
Osteoporotic 
Fractures 
N=6632 
4 years 65+ 
Benzodiazepine use, depression, low exercise 
level, low social functioning, body-mass index, 
poor visual acuity, low bone mineral density 
 
ADL 
Low exercise level was a modifiable predictor of 
functional decline in basic activities, not high BMI. 
Pinsky 1985 
USA (109) 
Framingham Disability 
Study 
N=2021 
27 years 28-62 
Hypertension, diabetes, smoking, BMI, 
cholesterol 
 
Cumulative disability index 
In women, hypertension, BMI, and diabetes were 
associated with disability; in men, only 
hypertension was associated with disability. 
For women current hypertension was associated 
with disability in the middle and old age groups. 
Diabetes was associated with disability in the older 
group, and smoking in the middle age. 
Reviews and/or meta-analysis for the outcome of disability: Keysor 2003 (physical activity) (149); Tak 2013 (physical activity) (96); Wong 2013 (diabetes) (135); Samper-Ternent 2012 (Obesity) (125). 
Life’s Simple Seven score includes cardiovascular health factors: smoking, body mass index, physical activity, dietary intake, blood pressure, glucose, cholesterol. 
LS7: Life’s Simple Seven; FRS: Framingham general cardiovascular risk score; MRI: magnetic resonance imaging; BMI: body mass index; IADL: instrumental activities of daily living; ADL: activities of daily 
living. 
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1.5 CEREBRAL SMALL VESSEL DISEASE 
Cerebral small vessel disease (SVD) refers to pathological processes affecting the arteries, 
arterioles, capillaries, and venules of the brain (150,151). The vessels vulnerable to SVD are 
essential for nourishing the brain and maintaining functioning of its metabolic areas and 
networks (150). In the past decade, SVD has been increasingly linked to not only clinical 
stroke, but also cognitive, psychiatric, and physical disabilities. For instance, research has 
suggested that SVD significantly contributes to cognitive impairment and dementia (152,153), 
conditions that place a huge impact on economy and society. In addition, evidence has emerged 
that SVD also plays a role in physical dysfunction, although the majority of current studies 
have been based on clinical settings (e.g. LADIS) (150,154,155). Despite the importance of 
SVD on future adverse health outcomes, very few population-based studies have investigated 
various markers of SVD and their aggregation in association with functional impairment in 
older people.  
Markers of SVD seen on magnetic resonance imaging (MRI) included in this thesis, encompass 
white matter hyperintensities (WMH), lacunes, and perivascular spaces (PVS). 
 
White matter hyperintensities 
WMH appear as hyperintense signals on T2-weighted and FLAIR images on MRI (156). WMH 
are increasingly common with advancing age and are known to be strongly associated with 
cognitive impairment, dementia, stroke, decreased mobility, and disability (151,156). They are 
also associated with the number of CRFs, such as hypertension, diabetes, and smoking (156). 
Studies investigating the association between WMH and physical performance in old people, 
specifically walking speed, are expanding. Many studies have shown consistently an 
association between greater WMH volume and increased risk of walking speed limitation 
(153,157-160), both cross-sectionally and longitudinally (see Appendix table 1 for cross-
sectional studies that are not included in the reviews). For example, it was demonstrated in 
a sample from the Oregon Brain Aging Study that higher total WMH volume was associated 
with an increased rate of decline in walking speed over 13 years in adults 65 years and older 
(161). It is assumed that WMH could interfere with motor and sensory tracts that are paramount 
for performing gait and balance. Research has suggested that subtle brain abnormalities can be 
observed in physical performance, even in high-functioning older adults (162). However, 
longitudinal studies in older adult populations are needed to understand this association. 
It has also been suggested that SVD is on the pathway between CRF and the decline in physical 
function. Hypertension has been most often examined in association with WMH, however, the 
potential role of WMH remains unclear. In the Three-City Study including adults 65-89 years 
of age, they found that the association between hypertension and walking speed decline was 
partly mediated by white matter lesions and lacunar infarcts (115). However, the longitudinal 
Cardiovascular Health Study found that WMH were not an intermediate factor in the 
association between hypertension and walking speed decline in older adults (114). 
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Lacunes and perivascular spaces 
Lacunes are defined as cerebral spinal fluid-filled cavities, and are often considered to be 
asymptomatic (150). So far lacunes have not been studied often in regards to physical function 
or disability. Some population-based cross-sectional studies showed no association of lacunes 
with walking speed performance (See appendix table 1), whereas longitudinally, it has only 
been investigated in a clinical setting of a stroke population (163).  
Perivascular spaces (PVS) are potentially enlarged compartments around blood vessels that run 
through the subarachnoid space and penetrate the brain parenchyma, and act as passages for 
carrying solutes and for lymphatic drainage (151,164). Population-based studies have shown 
that PVS are more frequent in older adults in the presence of hypertension and in those with 
carotid atherosclerotic plaques (165), and are correlated with other markers of SVD, such as 
WMH and subcortical infarcts (166,167), suggesting that PVS are a marker of SVD. Similar 
to WMH, PVS have been examined in relation to physical status only in very few studies, either  
cross-sectionally (168,169) or longitudinally in patient samples (167,170). One longitudinal 
study of 259 stroke patients found no association between PVS and functional limitation after 
three months (170), however, another longitudinal study in acute stroke patients PVS were 
associated with future mobility limitation after three years, but mobility was assessed according 
to self-reports (167). Longitudinal data from general population settings are lacking.   
 
SVD burden  
Despite all the various SVD being of vascular origin, they inherently contain slightly different 
etiopathophysiological features. Thus, it is also important to examine the combined or 
cumulative effect of these hallmarks of SVD on physical function, as the whole spectrum can 
provide a measure regarding the global burden (e.g. severity and intensity) of SVD damage in 
the brain. However, although an important topic, little is known regarding the functional 
phenotypes or consequences of cerebral load of SVD, and is only gaining interest recently 
(171). Global SVD burden has been examined in a normal aging population cross-sectionally 
(168), demonstrating an association with physical limitation, whereas longitudinally it has been 
mainly examined in stroke populations with conflicting results (163,170). This emphasizes the 
need for more population-based studies to better understand the relationships of individual 
markers and the global burden of SVD and physical function longitudinally in healthy older 
adults.
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1.6 KNOWLEDGE GAP 
 
A void of understanding persists regarding CRFs and biological and vascular pathways leading 
to late-life physical limitation and disability. First, it is well-established that walking speed is 
associated with increased risk of various adverse events, but its relationship with other mobility 
measures and the extent of its predictive power for disability in isolation and joined with other 
mobility limitations among older adults remains unclear. Second, earlier studies have focused 
on individual CRFs in association with physical limitation and disability, however, these CRFs 
often occur concurrently among older adults and may exert an accumulative effect on physical 
limitation and their progression, but this remains sparsely examined. Third, most studies have 
examined the association between CRFs and only walking speed, disregarding other physical 
function tests, which can provide us with more information. Finally, few population-based 
studies have investigated the pathophysiological mechanisms linking CRFs with deterioration 
in physical function in aging. Markers of SVD have been previously studied mostly in relation 
to cognitive outcomes, however, there is a lack of investigation into their association with 
physical function, especially longitudinally, except for WMH. Particularly, the role of lacunes, 
PVS, and the important role of the global burden of SVD on incipient physical function remains 
predominantly under-studied. 
In addition, earlier research has convinced us that disability has a tremendous negative impact 
on older persons and society and CRFs and physical performance are areas of intervention. 
Yet, studies have repeatedly been performed in middle-age populations to predict late-life 
consequences. There is a paucity of investigation into older population-based cohorts. Further, 
there is a lack of comparison between the younger-old and older-old. It is established that 
starting early is beneficial, but is it ever too late and which factors are most important?  
Moreover, studies investigating the risk of physical limitation or disability have not been 
performed in relatively healthy samples (e.g. free of physical limitation and CVD). 
Comprehension into the functional consequences of CRFs among older adults with good 
physical function and free of CVD can provide crucial information in developing useful tools 
for early intervention to postpone or even prevent the occurrence of the adverse events. 
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2 AIMS 
 
HYPOTHESIS 
We hypothesized that CVD-related risk factors and their aggregation play a crucial role in 
the atherosclerotic process in the absence of CVD, increasing the risk of physical limitation 
and inducing the progression to disability, even among older adults. Yet, differences may 
exist in regards to older age cohorts. Also, potential biological pathways leading to the 
progressive decline in physical limitation, may be through brain abnormalities of vascular 
etiology. 
 
GENERAL AIM 
The overall aim of this doctoral project is to investigate the role and potential 
neuropathological mechanisms of cardiovascular risk factors in the development of physical 
limitation and disability in older adults. 
 
SPECIFIC AIMS 
Specific aims will be addressed in a series of four individual studies, as specified below: 
Study I. To estimate the risk of developing disability in activities of daily living (ADL) 
according to limitations in walking speed, balance, or both in older adults. Further, to explore 
the role of chronic diseases and cognitive function in this association.  
Study II. To examine the association of the cardiovascular risk burden with the development 
of physical limitation in the younger-old (60-72 years old) and older-old (≥78 years) adults.  
Study III. To examine whether cardiovascular risk factors are associated with increased risk 
of disability, and to verify the role of functional limitation and age in this association. 
Study IV. To explore whether, and to what extent, imaging markers of cerebral 
microvascular pathologies are associated with incipient physical limitation in older adults. 
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3 MATERIALS AND METHODS 
3.1 SWEDISH NATIONAL STUDY ON AGING AND CARE IN 
KUNGSHOLMEN (SNAC-K) POPULATION STUDY 
 
General description 
The population-based Swedish National study on Aging and Care in Kungsholmen (SNAC-K) 
is an ongoing, longitudinal study undertaken in the urban district of Kungsholmen, Stockholm, 
Sweden, by the Stockholm Gerontology Research Center in collaboration with the Aging 
Research Center, Karolinska Institutet and Stockholm University (172). The purpose of SNAC-
K is to investigate and increase comprehension into the aging process and health of the general 
older population in central Stockholm for the development of preventative strategies. SNAC-
K is one of four longitudinal studies, as part of a national multi-center study called SNAC 
taking place in other regions of Sweden (http://www.snac-k.se/). 
Study population 
All the data for this doctoral project are derived from SNAC-K. The SNAC-K participants 
consist of a random sample of older adults, aged 60 years and older, living in their homes or in 
institutions on Kungsholmen. They were recruited between March 2001 and June 2004, at 
baseline, the sample was stratified into eleven age cohorts, with six year intervals between the 
younger cohorts (60, 66, and 72 years old), and a three year intervals between the older cohorts 
(78, 81, 84, 87, 90, 93, 96, and 99 years and above). This method was undertaken due to more 
rapid changes and higher attrition rates among older adults. Follow-up data were collected  
 
Figure 3. Swedish National study on Aging and Care in Kungsholmen cohorts, 2001-2013. 
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every six years for the younger age cohorts and every three years for the older-old age cohorts 
(Figure 3). By the year 2013, the first follow-up for young-old cohorts and the third follow-up 
for the older cohorts had been completed for SNAC-K. Of the 5111 persons initially invited, 
321 were ineligible and 200 died, leaving 4590 alive and eligible, of which 1227 (1227/4590, 
27%) declined before being called for the examination, leaving a sample of 3363 (73.3%) 
persons to participate at the baseline examination (Figure 4). For those unable to come to the 
research center (n=717), home visits were performed. 
In September 2001 to October 2003, a random sub-sample of noninstitutionalized, nondisabled, 
and nondemented SNAC-K participants across all age strata (n=555) were invited and agreed 
to have brain MRI scans. Only the fourth study of the doctoral project was based on the SNAC-
K MRI dataset. 
Figure 4. SNAC-K study population flowchart, by age group, from the baseline (2001-2004) initial 
random sample to the alive and eligible sample, and then the final examined sample, after excluding 
those who were ineligible, died, or declined. 
 
3.1.1 Study samples 
Study samples for this thesis were derived from SNAC-K baseline, 3-year (April 2004 to June 
2007), 6-year (July 2007 to October 2010), and 9-year (March 2010 to February 2013) follow-
up surveys. The SNAC-K MRI sub-sample was used for Study IV. Figure 5 shows the 
flowchart of participants for the four studies in this thesis. 
All the studies were longitudinal in study design. Study I included a total of 1971 participants, 
study II was composed of 3 sub-samples of 1441, 1154, and 1496 participants free of limitation 
in walking speed, balance stand, and chair stand, respectively, and CVD. Study III included 
1756 disability- and CVD-free participants at baseline, and 331 persons free of walking speed 
limitation in study IV. Study I used data up until 2010, while the other three studies used data 
until 2013. 
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Figure 5. SNAC-K Project and SNAC-K MRI study population flowchart. Figures illustrates number of persons at baseline, those excluded from the 
analyses (in perforated boxes), and the final analytical samples for studies I to IV. 
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3.2 DATA COLLECTION AND DEFINITIONS 
Data on demographics (age, sex, and education), physical functional status (e.g. walking speed, 
balance, chair stand, and ADL), global cognitive function (e.g. Mini-Mental State Examination 
[MMSE]), medical history, CRFs (e.g. smoking, hypertension, diabetes, obesity, and heavy 
alcohol consumption), and CVDs (e.g. coronary heart disease and cerebrovascular diseases), 
and current use of medications (e.g. antihypertensive, blood glucose-lowering agents) were 
collected at baseline and each follow-up, by physicians, nurses, and psychologists in 
accordance with standard protocols (available at http://www.snac-k.se/), which took about six 
hours to perform. Information was also gathered from Swedish National Patient Register and 
laboratory tests. Peripheral blood samples were taken, and glycated hemoglobin, serum total 
cholesterol, and genetic polymorphisms were determined following standard procedures. 
Cardiovascular risk factors 
Physical activity was assessed through the self-administered questionnaire asking how often 
light physical activity (e.g. walks on the street and parks, short bike rides, light gymnastics, 
golf) and high intensity physical activity (e.g. jogging, brisk long walks, heavy garden work, 
long bike rides, intensive gymnastics, long distance skating, skiing, swimming, ball sports) was 
performed in the last 12 months. This question was then dichotomized into active (weekly 
participation in physical activity of moderate-to-vigorous intensity) and inactive (less than 
weekly participation in physical activity of moderate-to-vigorous intensity), according to 
current recommendations (88,173). Alcohol consumption was assessed based on frequency 
and amount consumed on a typical drinking day, and was classified as none or occasional, light 
to moderate (1-4 drinks per week for men and 1-7 drinks/week for women), or heavy (>14 
drinks/week for men or >7 drinks/week for women) (174). Smoking status was recorded in 
study II as current or not current and as never or ever (current or former) in study III and IV. 
Seated arterial blood pressure was measured twice on the left upper arm with a 
sphygmomanometer, and the mean value was used for the analysis. Systolic blood pressure 
(SBP) was used as a continuous variable (Study II) or categorized into four groups (Studies III 
and IV), slightly modified from a previous study (175) (<130, 130-139,140-149, and ≥150 
mmHg) and diastolic blood pressure (DBP) in four categories (<70, 70-79, 80-89, and ≥90 
mmHg). Use of anti-hypertensive agents were classified according to the Anatomical 
Therapeutic Chemical classification system (ATC codes: C02, C03, and C07-C09).  High total 
cholesterol was defined as a nonfasting level of ≥6.22 mmol/l or use of cholesterol lowering 
agents (ATC code C10). Diabetes was defined according to self-reported history, records from 
the National Patient Register, the use of hypoglycemic agents, or ≥6.5% glycated hemoglobin 
level (176). BMI was determined according to weight in kilograms divided by the square of 
the height in meters and categorized as underweight (<20 kg/m2), normal (20-24.9), overweight 
(25-29.9), and obese (≥30). CRP is a common measure of overall inflammation level of the 
body. Serum CRP was measured following standard protocols, and high  CRP was defined as 
serum level  ≥5mg/L (177).  
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CRF burden 
Burden of CRFs was assessed using the Framingham general cardiovascular risk score 
(FRS) (143). The FRS includes: age, sex, systolic blood pressure, antihypertensive treatment, 
total cholesterol, high-density lipoprotein (HDL) cholesterol, smoking, and diabetes. However, 
we did not include HDL-cholesterol in our FRS algorithm, due to lack of data. The factors are 
sex-weighted and the total score is determined by summing all the factors together. A higher 
score indicates greater risk of a future cardiovascular event. 
 
Magnetic resonance imaging acquisition and measurements 
MRI protocol 
Participants were scanned on an Intera 1.5T scanner (Philips Healthcare, Best, the 
Netherlands). The protocol included an axial three-dimensional T1-weighted fast field echo 
(repetition time [TR] 15 ms, echo time [TE] 7 ms, flip angle [FA] 15o, field of view [FOV] 
240, 128 slices with slice thickness 1.5 mm and in-plane resolution 0.94 × 0.94 mm, no gap, 
matrix 256×256); an axial turbo fluid-attenuated inversion recovery (FLAIR, TR 6000 ms, TE 
100 ms, inversion time 1900 ms, FA 90o, echo train length 21, FOV 230, 22 slices with slice 
thickness 5 mm and in-plane resolution 0.90×0.90 mm, gap 1 mm, matrix 256×256); and a 
proton-density/T2-weighted  (TR, 3995 ms; TE, 18/90 ms; echo-train length, 6; flip angle, 90°, 
60 3-mm sequential images without a gap or angulation) sequence (178). 
MRI markers of cerebral small vessel disease 
WMH were manually delineated on the FLAIR images by a single rater (Grégoria Kalpouzos), 
and further interpolated on the corresponding T1-weighted images to compensate for the gap 
between slices in FLAIR. Intra-rater reliability was assessed with Dice coefficient, which was 
equal to 0.76 (SD 0.09) (for details, see Köhncke et al. 2016 (179)). WMH volume was adjusted 
for total tissue volume. 
Lacunes were defined as small lesions with cerebrospinal fluid signal on all sequences and 
surrounding high signals on FLAIR sequences. PVS were assessed using a visual rating scale 
(178). T1 and T2 images were used to assess PVS in different brain areas (e.g. frontal lobe, 
parieto-occipital lobe, basal ganglia, thalami) in each hemisphere. The number of PVS was 
scored in each region from 0-3: 0 (no visible PVS), 1 (1-5 PVS), 2 (6-10 PVS), or 3 (>10 PVS). 
Scores were then summed to a maximum of 24. All PVS assessments were undertaken by a 
clinical neuroradiologist (Anna Laveskog). Six months after, 20 randomly selected participants 
were rerated for PVS, demonstrating an excellent intra- and inter-rater reliability (both 
weighted κ=0.77). 
Cerebral SVD burden was evaluated using a score that included WMH, PVS, and lacunes, 
categorizing each into a dichotomous variable with values of either 0 or 1. A score of 1 was 
given to those who were categorized in the top tertile of WMH volume, in the top tertile of 
number of PVS, or had lacunes present. The value for each of the three SVD markers were 
then summed to create a SVD burden, ranging from 0 to 3. 
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Physical limitations and disability 
Physical performance measures included the one-leg balance stand, walking speed, and five 
times sit-to-stand chair stand tests, assessed by the nurse at baseline and follow-ups. Disability 
was defined according to basic activities of daily living (ADL) at baseline and follow-ups.  
One-leg balance stand was measured, asking the participant, without shoes, to stand as long 
as possible, up to 60 seconds, first on one leg then the other. Testing stopped if the participant’s 
foot touched the floor, if their bent foot was supported on the standing leg, if the standing foot’s 
position changed, if they lost balance, or reached the maximum time of 60 seconds. If they 
reached the maximum time on the first try, the second attempt was not pursued on that leg. 
Otherwise, each leg was tested twice and the best overall score was used. Balance limitation 
was defined as the common cut-off of < 5 seconds (67,180,181). 
Walking speed was assessed by asking the participants to walk for 2.44 or 6 meters. The 
distance was based on the participant’s self-rated usual speed. Self-rated fast or normal walkers 
completed the longer distance, whereas self-rated slow or very slow walkers performed the 
shorter walk. At home visits, the shorter walk was always performed, because of limited space. 
Walking speed is the time from whichever length was walked in the analyses, and is presented 
in meters per second (m/s). For participants who were unable to walk, a value of 0 m/s was 
recorded. The participants had a 2 m flying start before timing, to measure a consistent pace. 
Participants used their usual walking aids during the test. Walking speed limitation was defined 
according to the commonly used cut-off of a usual walking pace < 0.8 m/s (40,43,182). 
Chair stand was tested by asking the participants to fold their arms across their chests and to 
stand up from a sitting position once. If participants successfully rose from the chair, they were 
asked to stand up and sit down five times as quickly as possible. The time required to complete 
the task was measured in seconds (46). Chair stand limitation was defined as the inability to 
stand up from the chair. 
Dependence in basic ADL (i.e. bathing, dressing, toileting, transferring from bed to chair or in 
and out of bed, and feeding) was evaluated by counting the number of activities with which the 
subjects needed help. Disability was defined as the inability to undertake 1 or more ADL. 
Additional variables 
Confounding is one of the biases common in observational studies. Confounders were defined 
as variables that are associated with both the exposure and the outcome, however, not on the 
causal pathway. That is, the confounder is a risk factor for the outcome, and is associated with 
the exposure, but is not a result of the exposure (183). 
Global cognitive function was assessed using the Mini-Mental State Examination (MMSE) 
(184). DNA was extracted from peripheral blood samples using standard methods. Genotyping 
was performed using MALDI-TOF (Matrix Adsorbed Laser Desportion-Ionisation-Time Of 
Flight) analysis on the Sequenom MassARRAY platform at the Mutation Analysis Facility, 
Karolinska Institutet as described elsewhere (185,186), with minor modifications. For the 
current project APOE gene was analyzed and dichotomized as ε4 carriers vs. noncarriers. 
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Information on health history for all participants was also available from the Swedish National 
Patient Register where all in-patient care and specialized outpatient care services in Sweden 
since 1969 are recorded and can be linked to the SNAC-K database. Date of death was obtained 
from the Swedish Cause of Death Register. For health status criteria of the ninth and tenth 
revisions of the International Statistical Classification of Diseases and Related Health Problems 
(ICD-9 and ICD-10) were used. History of CVDs was ascertained by integrating data from 
clinical examination, electrocardiogram, and medication use collected during the study visit 
and information from the Swedish National Patient Register (187). We included four major 
CVDs, i.e., coronary heart disease (ICD-9 codes 410-414; ICD-10 codes I20-I25), heart failure 
(ICD-9 code 428; ICD-10 code I50), atrial fibrillation (ICD-9 code 427.8; ICD-10 code I48), 
and cerebrovascular disease (ICD-9 codes 430-438; ICD-10 codes I60-I69). Medical drugs 
were classified according to the Anatomical Therapeutic Chemical (ATC) classification system 
(ATC codes C02, C03, C07-C09) (188). 
3.3 STATISTICAL ANALYSES 
Statistical software Stata©, version 14 or 15 (StataCorp, College Station, Texas, U.S.A.) for 
Windows, was used to perform all statistical analyses. Table 4 displays the outcome variables, 
predictors, potential confounders, and methods of statistical analyses for all four studies of the 
thesis. 
For basic and descriptive statistics, Student T tests, χ2 tests, and ANOVA were employed to 
compare means of two groups of normal distributed continuous variables, when comparing two 
or more groups of categorical variables, and when the comparisons are more than two groups, 
respectively. Mann-Whitney U-test was used for skewed data. 
Prevalence of limitation in walking speed and balance, and ADL-disability at baseline stratified 
by age was estimated and incidence rates (events per 100 person-years) over the follow-ups 
were calculated (Study I). 
Binary logistic regression was used to estimate the odds ratio (OR) of ADL-disability 
associated with baseline mobility limitation (Study I) while taking into account follow-up time. 
In studies II, III, and IV Cox proportional hazards models were constructed to estimate hazard 
ratios (HR) and 95% confidence intervals (CI) for incident physical function limitations (Study 
II), incident ADL-disability (Study III), and incident walking speed limitation (Study IV) using 
follow-up time as the time scale, in relation to baseline FRS (Study II), CRFs (Study III), and 
markers of cerebral SVD (Study IV). Events were censored at first occurrence, otherwise 
censoring occurred at the end of the follow-up, or when participants died or dropped-out if the 
event did not occur. In studies II and III all analyses were stratified by age (60-72 and ≥78 
years) owing to potential interaction with age. All Cox analyses met the assumptions of 
proportionality.  
Linear mixed-effects models were also employed to examine average annual change in walking 
speed as a continuous variable in relation to baseline FRS quartiles and markers of cerebral 
SVD, in studies II and IV, respectively. Each linear mixed-effect models included a predictor, 
follow-up time, and an interaction term between the predictor and follow-up time. In study II 
models, age, sex, education, other lifestyle factors (BMI, physical inactivity, alcohol 
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consumption), CRP, and MMSE score were adjusted for. Models in study IV were adjusted for 
age, sex, education, CRFs, MMSE, CRP, APOE ε4 status, chronic diseases, and CVDs.  
Multinomial logistic regression was utilized when the outcome was multiple levels to assess 
also death as an outcome (Study I), otherwise competing risk analysis with Cox models was 
performed to take death into account (Studies II, III, and IV).  
Population attributable risk (PAR) estimates the proportion of new cases that would not occur 
if a particular risk factor was absent. PAR was calculated in study III using punafcc command 
in Stata after running the Cox models for CRFs that were significantly associated with ADL-
disability. It provides a useful quantitative estimate of potential effect of interventions to reduce 
or eradicate the risk factor. 
Statistical interactions were examined for chronic diseases and cognitive function with mobility 
limitations at baseline for incident ADL-disability (Study I), sex and FRS for various physical 
function limitations (Study II), CRFs and walking speed or sex (Study III), and markers of SVD 
and sex, age, or APOE ε4 status (Study IV), using a cross-product term, and considered to have 
potential statistical interactions at a P level <0.10. Joint effects were calculated in study I for 
baseline balance and walking speed limitation on incident ADL-disability, and in study III for 
combined baseline physical activity and walking speed status on future ADL-disability.  
Inevitably, in epidemiological studies missing data will occur. Missing data in the predictors 
can potentially lead to bias in the risk estimates and loss of statistical power. Two different 
methods of handling missing data were utilized in this thesis: dummy variable approach and 
multiple imputation by chained equation (189). Dummy variable method helps maintain 
statistical power, however, is only used with few missing data < 5%. Otherwise multiple 
imputation has been suggested as a valid and more appropriate method of filling in missing 
values and helping to maintain good statistical power. Missings were considered using the 
dummy variable approach for sensitivity analyses in studies I, II, and IV. Multiple imputation 
was undertaken in study III because 11% of the population was missing due to missing data in 
covariates.   
Time-varying covariates were also considered in Cox models for study II for MMSE and CVD. 
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Table 4. Outcomes, predictors, potential confounders, and main statistical analysis approaches used in 
the four studies included in the thesis. 
  
Study Outcome Predictors Potential confounders Statistical analyses 
Study I ADL-disability 
Balance and 
walking speed 
limitation 
Age, sex, and education, 
CRFs, MMSE score, chronic 
diseases 
Logistic regression 
models 
Study II 
Walking speed, 
balance, and 
chair stand 
limitation 
Individual 
CRFs and 
FRS 
Age, sex, and education, 
other lifestyle factors not 
included in the FRS (BMI, 
physical inactivity, 
alcohol consumption), CRP, 
MMSE score 
Cox models 
 
Linear mixed-effects 
models 
Study III ADL-disability 
Individual 
CRFs 
Age, sex, education, mutual 
CRFs, antihypertensive drug 
use, DBP, MMSE score, 
APOE  ε4, chronic diseases 
Cox models 
 
PAR 
Study IV Walking speed  
WMH, 
lacunes, PVS, 
SVD burden 
Age, sex, education, CRFs,  
MMSE score, CRP, APOE  
ε4, number of chronic 
diseases, CVDs 
Cox models 
 
Linear mixed-effects  
models 
ADL: activities of daily living; CRFs: cardiovascular risk factors; FRS: Framingham general 
cardiovascular risk score; CRP: C-reactive protein; MMSE: Mini-Mental State Examination; WMH: white 
matter hyperintensities; PVS: perivascular spaces; SVD: cerebral small vessel disease; BMI: body mass 
index; DBP: diastolic blood pressure; APOE: Apolipoprotein E gene; PAR: population attributable risk; 
CVD: cardiovascular disease. 
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3.4 ETHICAL CONSIDERATIONS 
The two major ethical concerns in regards to data collection for the Swedish National study on 
Aging and Care in Kungsholmen (SNAC-K) are informed consent and anonymity.  
Contacting the participants for SNAC-K involves multiple steps. First, participants are 
informed in writing and verbally. Initially, a personal letter is sent two weeks before the visit 
to explain the purpose, duration, and what is entailed in the study, and the role and importance 
of the participant. It is clearly stated that it is voluntary, and that they may discontinue at any 
time without expressing why. Then, a nurse calls the participants directly to confirm their 
participation in the study in order to set an interview time, followed by a letter being sent 
confirming the date and time of the interview.  In the case of the participant being cognitively 
impaired, the participant and a proxy (family member or caregiver) are asked to give consent. 
Both oral and written consent to participate is given by the participants. The participants are 
also asked whether they wish to be informed of disease status in the event of detection. If such 
a case occurs, their family doctor will be informed. Also, upon request reports on laboratory 
tests may be provided. The study follows the ethical principles described in the humanistic-
Samhällsvetenskapliga Forskningsrådet, in Sweden, in line with those expressed in the 
Declaration of Helsinki. 
During the examination to establish trust and comfort, assessments occur in a friendly and 
comfortable environment with sufficient time allocated. All tests were created to minimize 
discomfort of the participants during the examination. Considerations are also made in regards 
to the safety of the participants, for example, when performing the one-leg balance stand test. 
Nurses are nearby and assess if there is a risk of falling or injury, therefore they avoid the 
participant performing risky tests that can compromise their health. If at any time during the 
examination anguish or discomfort is expressed, the interview will be immediately terminated, 
regardless of whether the person or proxy has previously given consent. Feedback is provided 
to all participants regarding the progression and results of the research, either through seminars, 
brief reports, or popular scientific articles. 
At the SNAC-K center completed questionnaires are stored in locked drawers. The database 
group enter and save the data into the database system following the rules for security and 
privacy. Permission must be granted by the principal investigator of the SNAC-K study in order 
for researchers to utilize the data. Selected data that are distributed for research is only marked 
with a code, anonymizing the participants name and personal identification (personnummer). 
All researchers in SNAC-K follow the guidelines, as well all research in SNAC-K follows the 
principles established in the Declaration of Helsinki. 
SNAC-K received ethical permission for baseline and follow-ups of 3-, 6-, and 9- years 
(SNAC-K: Dnrs 01-114, 04-929/3, 2007/279-31, Ö 26-2007, 2009/595-32; 2010/447-31/2), as 
well as for the use of the Swedish Patient Register that covers all hospitalizations since 1969 
in Sweden and death certification (Dnr: 2009/595-32) from the Regional Ethics Review Board 
in Stockholm. 
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4 MAIN RESULTS 
Below are the main results from each of the individual studies in the thesis. For more details, 
see the published papers and manuscripts at the end of the thesis. 
4.1 MOBILITY LIMITATION AND FUTURE DISABILITY (STUDY I) 
At baseline of the 3060 persons, 5.0% had disability in activities of daily living (ADL), which 
was more apparent in those ≥78 years old than those <78. Figure 6 shows the age-specific 
prevalence of balance, walking speed limitation, and ADL-disability. 
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Figure 6. Prevalence per 100 of balance and walking speed limitation, and ADL-disability by age at 
baseline (n=3060). 
 
Prevalence of limitation was highest for the one-leg balance stand test, followed by walking 
speed limitation and ADL-disability across all age groups. Of note, the prevalence of disability 
increased tremendously after age 84 years (dashed black line in Figure 6).  
In the incidence analysis (n=1971, reported in figure 6), 119 (6.0%) persons developed ADL-
disability during the six years of follow-up, with an incidence rate of 1.5 per 100 person-years. 
Incidence rates for ADL-disability were higher for those with walking speed limitation than 
those with only balance limitation across all age groups.  
Having limitation in either balance or walking speed at baseline was associated with a greater 
likelihood of developing incident ADL-disability after six years of follow-up, even in the fully-
adjusted model, controlling for age, sex, education, baseline MMSE, and chronic diseases. The 
associations of physical limitation with ADL-disability were higher in those <78 years of age 
than ≥78 years of age. However, the changes in results from the demographic-adjusted model 
(age, sex, education) to the fully-adjusted model showed a greater attenuation in the estimates 
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in those who were ≥78 years of age than those <78 years of age. Also, there was a linear trend 
towards a decreasing balance or slowed walking speed over time being associated with a 
greater risk of disability (P <.001).  
Additionally, a joint effect was observed, where persons having limitations in both balance and 
walking speed simultaneously displayed the greatest risk of ADL-disability, than those having 
only balance limitation or only walking speed limitation (Figure 7). Results remained similar 
when death was taken into account.  
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Figure 7. Association between individually and combined limitation in balance and walking speed and 
incident ADL-disability (n=1971), adjusted for age, sex, education, follow-up time, chronic diseases, 
and MMSE score over six years. CI: confidence interval; ADL: activities of daily living. 
 
4.2 CRF BURDEN AND FUTURE PHYSICAL LIMITATION (STUDY II) 
In the analytical samples who were free of CVD and physical function limitation (walking 
speed n=1441; balance n=1154; chair stand n=1496), a heavier cardiovascular risk burden, 
defined according to the Framingham general cardiovascular risk score (FRS) was associated 
with increased risk of walking speed limitation (adjusted Hazard Ratio [aHR] 1.09, 95% 
confidence interval [CI] 1.02–1.17) in adults <78 years old, but not in those ≥78 years old (aHR 
0.98, 95% CI 0.92–1.03) over nine years of follow-up. The association between CRF burden 
and walking speed limitation was only evident in those 60-72 years of age. This association 
was still present after controlling for other lifestyle factors (physical inactivity, alcohol 
consumption, BMI), CRP, and MMSE score at baseline. Furthermore, there was a faster 
average annual decline in walking speed in those with the highest CRF burden compared to 
those with the lowest burden (Figure 8). There was an association observed between CRF 
burden and risk of balance limitation in the demographic-adjusted model in only adults <78, 
but this association became non-significant in the fully-adjusted model. There was no 
significant association found between the FRS and chair stand limitation. 
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Figure 8. Average annual decline in walking speed according to burden of cardiovascular risk factors 
defined by the Framingham general cardiovascular risk score (FRS) in adults 60-72 years old, 
controlling for age, sex, education, other lifestyle factors, C-reactive protein, and Mini-Mental 
Examination score. 
When the CRFs were examined individually in association with the various physical functions, 
in the younger-old adults (60-72 years old), physical inactivity, current smoking, diabetes, and 
obesity showed a strong association with future walking speed limitation. For balance 
limitation an association only occurred with being underweight, and for limitation in chair stand 
there were significant associations with diabetes, current smoking, underweight, obese, and 
physical inactivity. These associations persisted after taking death occurring during the follow-
up periods into account. 
 
4.3 CRFS AND FUTURE DISABILITY (STUDY III) 
In the analytical sample free of CVD and ADL-disability, among the younger-old (60-72 years 
old) physical inactivity (aHR 4.10, 95% CI 1.22-13.76), diabetes (aHR 5.61, 95% CI 1.17-
26.82), and high CRP (aHR 95% 2.78, 95% CI 1.07 -7.22) were significantly related with a 
greater risk of disability in ADL after nine years of follow-up, even after adjusting for age, sex, 
education, mutual CRFs, anti-hypertensive drug use, DBP, APOE ε4 status, MMSE score, and 
chronic diseases. There were no significant associations with other CRFs (alcohol 
consumption, smoking, hypertension, high total cholesterol, obesity). Among the older-old 
(≥78 years old) only physical inactivity was associated with a higher likelihood of incident 
ADL-disability (aHR 1.99, 95% CI 1.36-2.93).  
There was a significant interaction observed between physical activity and walking speed at 
baseline only in the older-old cohorts, such that being physically inactive and having walking 
speed limitation concomitantly, showed an even higher risk of ADL-disability (Figure 9). 
However, no interaction was observed between any other CRFs and walking speed limitation, 
and no interactions in the young-old cohorts. Eliminating physical inactivity would decrease 
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the proportion of people with disability by 42.7% as calculated by the population attributable 
risk.  Only after taking death into account the association between CRP and incident disability 
become significant, otherwise all other associations remained.  
Figure 9. Hazard ratio (95% confidence interval [CI]) for the association between baseline physical 
activity and incident ADL-disability by walking speed limitation status in adults 78 years and older 
(n=548), controlling for age, sex, education, mutual cardiovascular risk factors, anti-hypertensive drug 
use, diastolic blood pressure, APOE ε4, Mini-Mental State Examination score, and chronic diseases. 
 
4.4 CEREBRAL SMALL VESSSEL DISEASE AND WALKING SPEED DECLINE 
(STUDY IV) 
In the walking speed limitation-free MRI-sample of SNAC-K, at baseline, there was a faster 
average annual decline in walking speed in older adults with one (multiple-adjusted β 
coefficient -0.017, 95% CI -0.03, -0.004) or two or three SVD simultaneously (β -0.019, 95% 
CI -0.04, 0.001), compared to none. When examining individual markers of SVD, this 
association with walking speed decline was only significant for WMH β -0.020; 95% CI -0.035, 
-0.004) (Figure 10). 
Over the follow-up, 76 persons (23.0%) developed walking speed limitation. Of the three 
markers of SVD (WMH, PVS, presence of lacunes), WMH had a significant association with 
incident walking speed limitation occurring over nine years of follow-up (aHR 2.65, 95% CI 
1.25-5.61). This was visible in the fully-adjusted model, controlling for age, sex, education, 
MMSE score, CRFs, APOE ε4 status, chronic diseases, and CVDs. The significant association 
was mainly driven by blood pressure. There was, however, an association between greater SVD 
burden and limitation in walking speed (aHR 4.20, 95% CI 1.88-9.37). This association 
demonstrated a dose-response relationship, where with greater burden of SVD there was a 
higher risk of walking speed limitation, which was mainly driven by WMH. Taking into 
account death during the follow-up did not affect these associations. 
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Figure 10. Average annual change in walking speed according to baseline A) tertiles of white matter hyperintensity volume; B) the presence of lacunes; C) tertiles of 
perivascular spaces; and D) cerebral small vessel disease burden. All models were adjusted for age, sex, education, the Mini-Mental State Examination score, 
cardiovascular risk factors, APOE ε4, chronic diseases, and cardiovascular diseases (n=331).
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5 DISCUSSION 
5.1 SUMMARY OF MAIN FINDINGS 
In this doctoral project, the association between mobility limitation and incident ADL-
disability was investigated, as well as the association between CRFs and subsequent physical 
limitation and disability, in healthy older adults (free of physical limitation, CVD, or both). 
Furthermore, the possible underlying effect of small vessel vascular pathology, as detected by 
MRI structural brain abnormalities, was investigated in association with functional limitation. 
The main findings from this doctoral project are summarized as follows:  
1) mobility limitation can substantially predict the risk of subsequent ADL-disability, with 
limitation in walking speed showing a higher predictability than balance; 
2) CRF burden was associated with a greater risk of walking speed limitation in the younger-
old (age ≤72 years), but not balance or chair stand limitation, whereas CRF burden was not 
associated with any physical limitations in the older-old (≥78 years); 
3) multiple CRFs (i.e. physical inactivity, diabetes, and inflammation) seem to play the main 
role in the increasing risk of ADL-disability among the younger-old, whereas physical 
functional status (i.e. physical inactivity and walking speed) is more important among the 
older-old in the development of disability; and 
4) small vessel brain abnormalities are one of the underlying biological pathways leading to 
impairment in physical function.   
5.2 MOBILITY LIMITATION AND FUTURE DISABILITY 
In our population of people aged ≥60 years (mean age 73.7±10.8) we found the prevalence of 
ADL-disability to be 5.0% and the 6-year cumulative incidence to be 6.0%, with an incident 
rate of 1.5/100 person-years (Study I). In previous cohort studies, prevalence and incidence 
rates of ADL-disability varied due to heterogeneity in sample characteristics and follow-up 
lengths. For example, in two rural cohorts of Sweden the prevalence of ADL-disability was 
20.5% and 22.8% (190). In the rural Nordanstig cohort of northern Sweden, one of the four 
centers in the Swedish national SNAC project, the incidence of disability after three years was 
10.6%, but after six years was 28.1% in adults 78+, with incidence rates of 5.25 per 100 person-
years for disability in at least one ADL (18). This Swedish study also observed a substantial 
increase in the prevalence of ADL-disability after age 87 years (190), which was similarly 
observed in our study, where we saw a considerable increase after the age of 84 (Study I). 
Incidence rates of disability have been reported to range from 5.6-47% in other previous 
population-based studies (15). For example, in an Italian cohort the estimated incidence was 
7.3% over three years for ADL-disability (19). In a Finnish population of adults 60 years and 
older the incidence rate over five years was 14% (191), whereas in the Health, Aging and Body 
Composition Study the incidence of disability was 25% over 6 years (139). Similarly, in the 
Rotterdam study the incidence was 26.7% over six years follow-up (15). Another American 
community-dwelling cohort, Precipitating Events Project, it was reported that 18% of adults 
70+ years developed ADL-disability over three years at an incidence rate of 2.5 per 100 person-
year (55).  
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We demonstrated, in study I, that walking speed was the main predictor of ADL-disability in 
older adults, which was in accordance with other several studies (11,12,14,51,54,55,57,58,192-
194), even among high-functioning older adults (45,46). A pooled analysis of seven studies 
containing 27 220 adults 65 years and older, showed that walking speed was a significant 
predictor of incident disability (192). In regards to the relationship between walking speed and 
balance and future disability, it has been mainly observed that balance is of lower predictive 
value than walking speed in functional decline. One study of Japanese older adults showed that 
the balance test had the second highest predictive value after walking speed for functional 
dependence in adults age 75 years and older (14). Comparably, the tests that reflect balance 
and control became non-significant predictors of ADL-disability when added in the model with 
walking speed in a Norwegian study (12). However, conflicting results have also been reported, 
such as one study in the US showing balance to be a stronger predictor of ADL-disability than 
walking speed over 18 months in adults with an average age of 80.3 years (16), and another 
study of Japanese adults 65-74 years old where the one-leg balance stand test was a stronger 
predictor of ADL-disability than walking speed after six years of follow-up (14). In the 
American study the reason balance demonstrated a stronger predictability than walking speed 
was due to the more complex nature of the test administered. However, in the Japanese sample, 
where the same test was used as in this thesis, this may reflect the early decline in balance prior 
to walking speed, as balance’s stronger predictability was only evident in younger-old adults, 
but not the older-old. 
Few studies have taken into consideration the temporal and predictive hierarchy of physical 
functioning decline, where balance deteriorates prior to gait or displays a weaker predictive 
value for disability. Indeed balance is also an important component of completing daily 
activities, deteriorating also with age (195), with its diminishment further affecting the course 
of disease to disability (196). Therefore, balance adds worth in identifying the early markers 
leading to the loss of independence. Furthermore, biomechanically, balance is a chief 
constituent and prerequisite of human gait. Standing balance involves sensory input and 
neuromuscular control, so that perturbations on the body, such as in walking, requires greater 
effort for one to maintain their center of gravity within their base of support (197,198). Thus, 
impairment in standing balance may indicate changes in the muscular and neurological systems 
that may occur prior to walking speed impairment (197,199).  
Walking speed, one of the most informative measures of health and strongest predictor of future 
adverse health events. Walking requires a combination of multiple systems to work 
simultaneously, such as cardiovascular, neurological, and respiratory. Any slight disruption in 
these biological systems will directly affect gait and manifest in a slowed speed, even without 
overt diseases. Walking speed has been repeatedly used, displaying independence in predicting 
disability, even demonstrating superiority to a whole battery of tests, and capability to predict 
survival (40,43,192,200). Although, walking speed is a great indicator of future health events 
– as reported in one review of 12 studies, where walking speed was presented as the most 
powerful indicator of disability (79) – other physical functions can give us even more 
information for early detection of risk of disability, as we showed in the combined effect of 
balance and walking speed limitation (Study I). Therefore, this project highlights the usefulness 
of other tests, such as the simple one-leg balance stand test, in being an early indicator of high-
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risk older adults to prevent the risk of disability, and also emphasizes the aptness of the walking 
speed test in providing even more information. 
5.3 CRFS AND PHYSICAL FUNCTION LIMITATION AND DISABILITY 
CRFs are important risk factors for an underlying cardiovascular pathology that has not yet 
manifested overtly as CVD. It has been reported previously that CVD is the most common 
disorder in the SNAC-K population among those 75 years and older (39.9%) (201) and CRFs 
are highly prevalent (85).  The results from this doctoral project show how these modifiable 
risk factors can be detrimental to an older adults’ physical health and increase their risk of 
developing disability even among relatively healthy older adults. Earlier studies have also 
noted the association between individual CRFs and physical function (62) (See Table 2 in the 
Background). However, most studies did not exclude those with chronic conditions especially 
with regard to CVD. As well, walking speed has been mainly investigated, showing that high 
cardiovascular risk can lead to a slower walking speed, while other physical functions have 
been neglected or chiefly included in physical performance batteries, rather than teased apart.  
We showed evidence that CRFs seem to play a more important role in the decline in walking 
speed than in other physical functions, such as balance and muscle strength (Study II). As well, 
this was independent of other chronic conditions and cognitive function, and was observed in 
a healthy older population.  A decline in walking speed illustrates deficiencies in several organ 
systems (i.e. neurological, cardiovascular, respiratory). Thus, walking speed is not only a 
measure of physical function, but also of subclinical conditions (202). This again reinforces the 
importance of the walking speed test as a tool to detect older adults at risk of losing their 
independence and decreasing quality of life. CRF burden did show an association with future 
poor balance initially (Study II), but this association disappeared after controlling for other 
lifestyle factors, inflammation, and cognitive function. Plus, when examining the individual 
vascular factors, most showed no association with balance in our older adult population. Thus, 
this affirms that disruptions in balance are less affected by changes in the cardiovascular 
system, as depicted in walking speed, but rather balance is more influenced by weakening in 
sensory systems. Furthermore, similar CRFs (e.g. physical inactivity and diabetes) found to 
predict disability in study III, also predicted walking speed limitation in study II, hence 
suggesting that the underlying pathology leading to walking speed decline is more similar with 
disability than balance’s underlying pathology. 
Earlier studies have also reported the association between individual CRFs and the 
development of disability (See Table 2 in the Background), as we have observed (Study III), 
although, we observed this in a healthy older population. Additionally, there was a modifying 
effect of walking speed on the association between some CRFs and disability, such that there 
was a greater risk in those who also had walking speed limitation (Study III). This has not been 
previously investigated, but emphasizes the similar pathway in the progression from physical 
limitation to disability. Thus, it is important to concentrate on both physical and cardiovascular 
factors in order to help older adults maintain independence longer. 
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5.4 INDIVIDUAL VS. COMBINED CRFS 
We found that a combination of CRFs can give us a good picture of the risk of future poor 
physical function, but its individual components can elucidate additional information so that 
effective interventions for the prevention of physical limitation can be developed. Specifically, 
we found that physical inactivity, diabetes, current smoking, and obesity were associated with 
increased risk of walking speed limitation over the follow-up (Study II), which is in line with 
other studies (107,135,149). We only observed this in a sample of 60-72 years old. Other 
samples of other studies were predominately younger (e.g. middle age) than our sample. The 
association between physical inactivity and disability has also been repeatedly demonstrated in 
previous literature, and shown to be one of the fundamental factors in the progression to 
disability (96).  
The concomitant effect of CRFs on physical function in older adults has been little investigated 
(130,132,134), although older adults are more likely to experience multiple conditions 
simultaneously (203). One study examined the FRS in relation to physical limitation in a 
middle-age population (204). This study also found the FRS to be most strongly associated 
with walking speed limitation, and less with the other physical functions. Another metric, the 
American Heart Association’s Life’s Simple 7 (205), which includes seven cardiovascular 
health factors, also demonstrated that ideal cardiovascular health can decrease the risk of 
physical limitation (131,132,134). However, this algorithm, includes other factors (e.g. diet) 
and is not as well-established than the FRS. It also does not assess risk, but rather the protective 
nature of the cardiovascular factors. Our study adds to the literature, the association between 
aggregated CRFs and various physical function tests of the lower extremities, to give a more 
holistic picture, to evaluate where efforts should be directed. 
5.5 VARIATIONS BY AGE 
 Age appears to have an impact on the association between physical limitation and incident 
disability (Study I), but also on the associations between CRFs and physical limitation and 
disability (Studies II & III). However, there is a paucity of studies investigating variations by 
age and the age-effect remains under debate. We found that the association between mobility 
limitation and ADL-disability was stronger in the younger-old (age <78 years) (Study I), as 
well as the association between CRFs and walking speed limitation and disability (Studies II 
& III), whereas in the older-old physical decline might be most crucial than underlying 
alterations in the vasculature. In study II we utilized the FRS, which was originally developed 
for adults younger than 75 years, which may account for the age differences, however, we 
believe there is still an age effect, as observed in the other studies in this thesis and from other 
literature. In a population of older Japanese adults, they found that over the six year follow-up, 
one-leg balance stand test was the most sensitive predictor for disability among those 65-74 
years old, but walking speed was for those 75+ (14). This supports the idea of physical function 
being more important in the older ages. As well, age variation was also observed for diabetes 
and disability in women from the Study of Osteoporotic Fractures, showing a significant 
association between diabetes and incident disability only in women 65-79 years old and not 
≥80 years (136). Comparably, another study found an association between subclinical 
cardiovascular abnormalities and physical limitation over time, but not with ADL-disability 
among adults 40-80 years old free of CVD (206). They found that the association between 
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subclinical cardiovascular abnormalities and physical limitation was only present in the 
younger-old, which is in line with our results. 
Potential reasons for these age differences are not only due to variations in the measurement 
tools, but also partly pertaining to the concept of “adaption” or the protective nature of CRFs 
in older age. The idea of “adaptation” is in regards to changes occurring from a restriction in 
blood supply among the older-old, where a limited blood supply is compensated for by distal 
autoregulatory dilation (206). The findings of the present study suggest that the younger-old 
are still undergoing a process of adaptation, whereas the older-old have adapted to a restricted 
blood supply, thus physical function is not as affected. Moreover, other studies have also 
exhibited an opposite effect of some risk factors on adverse health outcomes in the older-old, 
presenting a more protective effect. For example, alcohol consumption, hypertension, and BMI 
have demonstrated a J or U-shaped association with risk of CVD, cognitive impairment, and 
physical dysfunction in some studies (175,207-209). Therefore, although these factors might 
have a risky effect in middle-age or younger-old age, they could become protective factors in 
old age. This might also explain the lack of associations between some CRFs and functional 
limitation among the older-old.  
It has also been proposed that CRFs may be instead markers of robustness, i.e., not being frail. 
One study of adults 65 years and older in the US, showed that the association between blood 
pressure and mortality decreased with age, but the prevalence of frailty increased with age 
(210). Among the oldest adults it is common that blood pressure decreases and low blood 
pressure has been shown to be associated with increased risk of mortality (175). Plus, another 
study showed that blood pressure did not predict mortality among healthy adults 75 years and 
older (113). This is explained by low blood pressure in frail older adults being an indicator of 
an imminent critical event (e.g. heart failure and death), however, not among healthy older 
adults (113). The Study of Osteoporotic Fractures including women 65 years and older also 
demonstrated that diabetes was not associated with physical dysfunction in healthy women 80 
years and older, over 12 years of follow-up (136). Thus, the lack of an association between 
CRFs and physical limitation and disability in the older-old, observed in this thesis, is more 
likely a result of them being robust, healthy older adults where CRFs do not increase the risk 
of negative health events. 
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5.6 BIOLOGICAL MECHANISMS 
Figure 11. Potential pathways linking cardiovascular risk factors to physical function decline and 
disability in older adults. 
The underlying biological pathways linking CRFs to physical function decline and disability 
are displayed in Figure 11, extending from the WHO’s ICF framework, focusing on the 
medical and biological perspective aging. The changes in physical function that occur with 
aging can be affected by an underlying cardiovascular pathology instigated by poor lifestyle 
and cardiometabolic profiles, promoting the atherosclerotic process. In turn, this can damage 
central and peripheral systems, consequently, either directly causing physical dysfunction and 
increasing the risk of disability, or going through age-related injury to the brain, subsequently 
impairing physical functions and accelerating the development of disability. In this thesis we 
were able to study the associations depicted with the gray arrows. 
 
5.6.1 Atherosclerotic process and peripheral changes 
The underlying process by which CRFs increase the risk of CVD is through atherosclerosis, 
which is also believed to primarily explain the decline in physical function and disability. We 
found that some specific CRFs were more associated with future functional limitation than 
others, such as physical inactivity, diabetes, smoking, and obesity. Furthermore, improvements 
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in these CRFs will also produce favourable effects on each other by enhancing health of the 
cardiovascular system and also cause peripheral changes. For instance, increasing physical 
activity will also prove beneficial for blood pressure, cholesterol, insulin sensitivity, and 
inflammation, among other factors. Also, independently, physical activity, boosts physical 
function by positively effecting cardiac function by improving myocardial contraction, 
myocardial oxygen supply, and electric stability, but also promotes increased muscles mass, 
strength, and quality, and production of pro-inflammatory myokines (83,211). Smoking has 
substantial negative effects on vessels and also on the musculoskeletal system and it is known 
that cessation can immensely reduce the risk of CVDs, which in turn can have a positive impact 
on physical abilities. Diabetes also is known to have significant negative effects on physical 
capabilities. Diabetes damages muscle tissue and is associated with obesity and increased 
inflammation (117). Consequences of long-term diabetes are peripheral neuropathy and 
peripheral atrial disease causing impairment in skeletal muscles and muscle atrophy, but also 
increased protein degradation and decreased protein synthesis, as well as mitochondrial 
dysfunction and oxidative stress (147). 
5.6.2 Inflammation and cognitive function 
Low-grade chronic inflammation is also a common characteristic of the aging process, also 
termed “inflammaging”, but can have detrimental consequences (137). CRP is one of the most 
common markers of inflammation and has been shown to lead to vascular damage and insulin 
resistance (137). Thus, our study adds to the literature showing an association between CRP 
and disability (Study III), however, not with the physical performance tests (Study II). Yet, 
inflammation is known to augment the atherosclerotic process (117), and is linked with loss of 
muscle mass and strength, termed sarcopenia. Also, with age there is fat accrual, in turn 
increasing the risk of other risk factors, such as diabetes, hypertension, and dyslipidemia. These 
may act synergistically leading to adverse health events. Fat accumulation can cause 
dysregulation of adipokines and infiltration of macrophages and other immune cells, producing 
pro-inflammatory cytokines and chemokines, leading to inflammaging. In turn, sarcopenia and 
insulin dysfunction can develop. Obesity leads to a heightened production of fatty acids that 
can accumulate in skeletal muscle as intramyocellular lipids (IMCLs). These IMCLs damage 
contractility of muscle fibers, reducing strength and power. They also impair fatty acid 
oxidation and increase reactive oxygen species leading to apoptosis (cell death) of muscle cells, 
thus a main agent in the pathogenesis from obesity to sarcopenia (212). 
Cognitive function has also been suggested to be a possible reason for the association between 
CRFs and physical function, as CRFs also are associated with worse cognitive performances. 
Additionally, it is a well-known relationship between cognitive performance and gait, 
demonstrating a need for higher order cognitive performance (213). Furthermore, there is a 
suggested similarity in the underlying decline in physical and cognitive function with age (214). 
However, the associations between FRS/CRFs and physical limitation and disability remained 
after controlling for cognitive status (Studies II & III). Comparably, in the Whitehall II cohort, 
their association between the FRS and motor function decline also was not explained by 
cognitive function (130). 
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5.6.3 Cerebral small vessel disease 
The relationship between CRFs and physical function, may also be partly explained by 
underlying structural brain abnormalities that occur with aging, such as cerebral small vessel 
disease (SVD). Although not necessarily pathological, these abnormalities are of vascular 
origin and potential mediators on the pathway leading to functional decline, hence genuine 
preclinical conditions. Previous studies have indicated a potential mediating effect of markers 
of SVD on the association between CRFs and future physical function (115,215,216), 
suggesting that brain abnormalities are possible mediators on the pathway from subclinical 
cardiovascular pathology to physical limitation and even disability. A study, however, did find 
that WMH did not mediate the association between hypertension and walking speed decline 
(114), but this was explained by the issue of timing, as the exposure and mediator could be 
measured too closely in time to apprehend a mediating effect. For example, high blood pressure 
is shown to have an incubation period of five years prior to noticeable changes on organ 
systems. In our sample we were not able to do a mediation analysis to confirm this hypothesis 
due to relative small MRI sample and weak associations between CRFs and physical limitation, 
however, the lack of associations was possibly due to the fact that our sample was quite healthy 
and that the adverse health impact of certain CRFs (e.g. high blood pressure, high BMI) may 
decrease or even reverse as people age, as explained earlier (see section “Variation by age”). 
Nevertheless, the link between long-term exposures and CRFs from middle age onward with 
cerebrovascular damage (e.g. SVD) has been well established, and we do find an association 
between different markers of SVD and global SVD burden and a decline in walking speed over 
time.  
The exact mechanisms by which SVD disturbs motor function in the vascular pathway is 
unclear. It is hypothesized that SVD negatively affects structures of the brain required for motor 
function. For instance, WMH are presumed to disrupt the sensorimotor tracts in cortical and 
deep matter regions (159,217). Projection fibers, commissural fibers, and association fibers are 
believed to be disrupted by WMH leading to physical dysfunction (159). These fibers 
communicate with sensory processing areas needed for planning and the executing of 
locomotor functions in the parietal lobe and basal ganglia (159). Specifically, WMH in the 
periventricular regions are believed to be most damaging (218). Also, recently studies suggest 
that microstructural integrity of white matter, measured with fractional anisotropy, may be the 
reason linking white matter changes and mobility decline. One study found an association 
between more WMH and slow gait in older adults with low integrity of the white matter (219). 
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5.7 METHODOLOGICAL CONSIDERATIONS 
The SNAC-K population study is a large population-based study with a generous sample size, 
comprehensive data, objective measures of physical function, and assessments carried out by 
trained health care professionals. However, like every epidemiological study, issues of random 
and systematic error may arise. Specifically, random error from sampling and measurements, 
and bias concerning selection, information, and confounding are of most consideration. Our 
studies were designed and the methods chosen in order to reduce potential bias as much as 
possible and consequently to increase their internal validity. 
Random error 
Random error or lack of precision often occurs in epidemiological studies from population 
sampling and measurements. Sampling variance results from the sample not mirroring the 
population due to heterogeneity in the population. This error can be reduced by increasing the 
sample size to improve homogeneity and precision. Measurement error arises from random 
variation in measurements. For example, the walking speed test was only performed once in 
our study during each assessment. Repetition of the test may decrease the random error, 
however, it has been previously reported that even among stroke patients one measure of 
walking speed is reliable (220), thus we assume minimal error in our studies. 
Selection bias 
Selection bias can occur from the recruitment of individuals into the study or from the 
plausibility of retaining them in the study. This bias can usually lead to an underestimation of 
the examined associations, because the sample selected often does not reflect the population 
from which it was drawn. In the recruitment an imbalance can manifest in the association 
between the exposure and outcome due to the procedures of selection and from factors 
associated with the participants. Also, differences can occur between those who participated in 
our sample and all those who were eligible, including those who did not participate, leading to 
bias. However, prospective studies have the advantage of minimizing this bias, because the 
exposure is measured at baseline, prior to the outcome. As this is a longitudinal study, 
participants are likely to drop-out for various reasons, such as from moving away or death. In 
turn, this can impact the results, because characteristics of those who dropped-out during the 
follow-up and those who remained until the event or the study end may differ. In SNAC-K, the 
response rate at baseline 73.3%, which is considered high. The drop-out rate at 3-years was 
37.3%, and this was mainly in the older age cohorts and due to death (27.6%), while only 9.6% 
declined to participate or moved. The drop-out rate at 6-years was 25.8%, of which 14.6% died 
and 11.2% declined or moved. At 9-years the drop-out rate was 30.8% of which 23.5% died 
and 7.3% were nonparticipants. Therefore, the predominate reason for attrition was death. 
Drop-outs during the follow-ups in all studies could thus lead to an underestimation of the true 
strength of the association. Overall and as expected, the characteristics of those who refused to 
participate and those who moved away or died, compared to those who remained, were more 
likely to be older, women, and have lower education.  
In studies I-IV missing data were taken into consideration either through the dummy variable 
method or multiple imputation by chained equation (189). This was used to evaluate how 
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missing data might affect the observed findings. Overall, the results were similar between full 
case analysis and imputed analyses, suggesting missing data had no significant impact on the 
results from the analytical sample.  
Information bias 
Measurement error or inaccurate assessment of exposures, outcomes, or covariates can lead to 
information bias in epidemiological studies. In turn, misclassification of the main variables 
utilized in the main analyses can transpire. To avoid or reduce systematic error, study nurses 
and doctors underwent training prior to data collection to ensure that they followed the same 
procedures during repeated interviews and assessments. Standardized study protocols, 
procedures, and diagnostic criteria were used, and the data collection staff turnover was low.  
Misclassification of exposures: Information on CRFs were collected through various sources 
to minimize the information bias. For example, information on behavioural CRFs (physical 
activity, alcohol, and smoking) were collected by trained nurses through structured interviews. 
If the participant was unable to respond, such as due to cognitive impairment, next-of-kin was 
interviewed instead. Although, proxy interviews may relay inaccurate data, the use of multiple 
sources helped to minimize the bias. Cardiometabolic risk factors, such as hypertension, 
diabetes, cholesterol, and obesity were gathered from face-to-face interview-based 
questionnaires, national patient register, drug use, clinical examination, and blood tests. 
Structured interviews are of higher quality and validity than self-administered questionnaires, 
but also even with interviews, participants are likely to misreport behaviours. For brain 
measures, while standard assessment protocols and validated rating scales and approaches have 
been followed, brain disorders may have influenced the calculations of volumes, therefore we 
excluded those who had relating brain disorders from Study IV. 
Misclassification of outcomes: Physical function and disability were objectively assessed by 
trained nurses who followed a specific protocol that has been used repeatedly in other studies. 
These tests were however only performed one time per visit. Random measurement error might 
have been reduced if the test was repeated several times. Walking speed was measured with 
standard protocol, therefore systematic error was lessened, however, bias may arise due to the 
differences in walking distance. Those who reported a usual fast pace were tested over 6 m, 
while those who reported a slow usual pace were tested over 2.44 m. Notwithstanding, the 
results of the two tests have been shown to be comparable (221). ADL could have been affected 
by false recall of participants, however in the interview after the participant reported their ADL 
status, the nurse also reported whether they agreed/disagreed with the participant’s response. 
If the nurse was unsure about the participant’s judgement, they contacted a proxy. This 
occurred especially in cases where the participant had cognitive impairment. 
Confounding 
Confounding pertains to the independent association of the exposure and the outcome each 
with a third variable. The confounding associations are not causal, but if a confounder is not 
accounted for, it may lead to either an overestimation or underestimation of the observed effect. 
Although, impossible to control for unmeasured or unknown confounders (residual 
confounders), because of lack of information or deficient assessment, we carefully chose and 
 50 
assessed major potential confounders in each of the four individual studies included in the 
thesis, and proper assessment methods were undertaken.  
Generalizability 
Generalizability, also termed external validity, pertains to the transferability of the results to 
other populations in order to make unbiased inferences. The SNAC-K population abides in an 
urban area on an island in Stockholm. Residents in this area are characterized as having a high 
level of education and mainly in white collar occupations. Therefore, we can expect this 
population to have a lower risk of chronic conditions and disability compared to the national 
average. However, the results do provide us with important information regarding older adults’ 
health in general. Although, greater attentiveness may be necessary when comparing to 
populations with lower socio-economic status or countries with different healthcare systems. 
Furthermore, the SNAC-K MRI sample requires also special consideration as this sample’s 
demographics differ slightly. This sample is characterized as being more likely to also have a 
high education, but more likely to be younger and men. Thus, these characteristics need to be 
acknowledged when comparing to other study populations. 
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6 CONCLUSIONS 
1. Walking speed is a strong predictor of future disability, however, when combined with 
balance function, a greater understanding of future functional dependence can be 
gained. 
 
2. An increasing burden of CRFs is associated with increased risk of limitation in walking 
speed among older adults free of CVD and physical limitation, suggesting that 
interventions targeting multiple CRFs similtaneously may potentially decrease the risk 
of physical limitation and disability among relatively healthy older adults. 
 
3. Modifying cardiovascular health may be most important for the younger-old in 
decreasing the risk of physical limitation and disability; whereas improving physical 
function is more important for the older-old, in high-functioning older adults. 
 
4. Vascular brain lesions substantially contribute to an accelerated decline in walking 
speed as one of the main underlying pathologies. 
 
 52 
7 RELEVANCE AND IMPLICATIONS 
Remaining functionally independent and having a good quality of life into old age is more 
fundamental to older adults than longevity. Moreover, with the increasing aging population we 
not only expect an increasing proportion of older adults, but also a colossal number of those 
requiring care. The risk of disability increases with age and can be burdensome for the 
individuals, but coupled with the projected rise in the older population this will also become 
cumbersome for families, caregivers, and the society. Disability is considered the main reason 
for increases in healthcare costs. Thus, this project is highly relevant in discovering meaningful 
points of intervention, in order to implement effective public health strategies. It is paramount 
to understand functional decline at the early stages and those factors that can accelerate the 
progression to physical impairment and disability that are in line with the underlying biological 
pathway. CVDs persist as the leading causes of death globally and even so among older adults 
and our studies show that CVD-related risk factors are drivers of loss of physical function and 
independence. Our results show that disability may be more effectively delayed if efforts in 
developing interventions are made towards reducing cardiovascular risk in the younger-old 
adults, and towards improving physical functions more in the older-old. Thus, at the public 
health level and in the development of health policies, means of improving cardiovascular 
health and physical capabilities to lengthen an older adult’s time of independence should be 
integrated.  
Furthermore, in clinical and epidemiological settings, we support the use of easily 
administrable mobility tests as means of detecting older adults at risk.  These tests not only 
provide information regarding underlying pathology, but can help identify stages in physical 
decline, as balance, for instance, declines prior to walking speed. Thus, these pragmatic 
performance tests can provide essential information to the clinician when assessing geriatric 
patients in order to decide what further assessments are necessary. Furthermore, neuroimaging 
technology can provide us with deeper information regarding the subclinical changes occurring 
that could induce the progression further. Thus, clinically, this project highlights the need for 
use of physical function tests and MRI-imaging to comprehend not only the physical status, 
but underlying pathologies arresting physical function and accelerating the progression to 
disability to identify older adults at risk early.  Consequently, these studies can provide insight 
at both the individual and societal level.
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8 FUTURE DIRECTIONS 
In this doctoral project comprehension was obtained concerning the association between CRFs 
and future physical limitation and disability, and the association of markers of SVD with 
walking speed decline. Further studies are required to gain greater insight concerning the 
involvement of CRFs and biological pathways in the development of physical limitation and 
its progression to functional dependence in older adults. Specifically, a large-scale population-
based study that integrates both epidemiological and clinical data assessed at middle age and 
later in life with objective measures of physical functioning and imaging markers of brain 
lesions will help gain a greater understanding of the underlying biological mechanisms and the 
role of CRFs and SVD on the progression from physical limitation to disability. This would 
allow for stratification by age cohorts, as well, as investigation into differences by chronic 
conditions (e.g. exclude /include those with CVD). 
Additionally, various physical functions can be studied in the future to establish their link in 
the vascular pathway and how they interact with each other to further extend knowledge into 
the ordering of decline in lower extremity function. In turn, this would allow for interventions 
to be developed more precisely.  
Investigation can also be made into CVD-related genes that may predispose older adults to 
increased risk of not only CVD, but also physical dysfunction. Thus, genetic risk scores can be 
created to illuminate the joint effect of putative risk genes and identify older adults at greater 
risk of disability. Consequently, further investigation can be made into whether CRFs may 
modify one’s genetic predisposition in order to mitigate the negative effects of the risk alleles.  
Subsequently, a greater understanding of risk factors and heredity may allow for the 
development of multi-domain interventions. Randomized controlled trials can be performed to 
test if we can improve older adults’ health and reduce the risk or hinder the onset of physical 
limitation.  
Furthermore, future studies can extend the ICF model to incorporate environmental and 
personal factors that plausibly influence the transitions in physical function over time, allowing 
older adults to be functional with technological aids and devices. This might further elucidate 
a potential integration of medical and social factors. Consequently, this transdisciplinary 
perspective may aid in reaching the needs of older adults from other angles through therapeutic 
and preventative interventions not only biologically but also contextually. 
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11 APPENDIX 
Appendix Table 1. Population-based cross-sectional studies on the association between cerebral small vessel disease and walking speed limitation. 
Author, year Study population Age SVD Outcome measures Main results 
SVD burden      
Su 2017  
China (169)  
 
Shunyi study, N=770 35+ WMH, lacunes, CMBs, PVS, and 
brain atrophy 
 
Walking speed WMH were negatively associated with walking 
speed, and positively associated with chair-
stand time. Lacunes, CMBs, or PVS were not 
associated with motor performance. 
Pinter 2017 
Scotland (168) 
 
Lothian Birth Cohort 
1936, N=678 
71–74 SVD markers (WMH, microbleeds, 
lacunes, perivascular spaces, brain 
atrophy) 
Walking speed WMH and global SVD score were predictors of 
walking speed. 
Individual CRFs     
Baezner 2008 
11 European 
countries (222) 
LADIS, N=639 65-84 Age-related white matter changes Walking speed and balance Limitation in walking speed and balance 
performance were associated with the severity 
of age-related white matter changes.  
Rosano 2010  
Iceland (223) 
 
AGES-Reykjavik Study 
cohort, N=795 
Mean 
75.6  
WMH, brain atrophy, brain infarcts Walking speed Higher WMH were associated with slower 
walking speed.  
Smith 2015 Canada 
(224) 
 
Prospective Urban Rural 
Epidemiological 
substudy (PURE-MIND), 
N=803 
40-75  Silent brain infarcts-Lacune, CMBs, 
and WMH 
 
 
Timed Up and Go test of gait Silent brain infarcts were associated with slower 
gait. Higher volume of WMH was associated 
with slower gait. 
Kim 2016 
USA (225) 
 
Cardiovascular 
Health Study, N=2452 
65+ Microvascular abnormalities (brain, 
retina, kidney) and macrovascular 
abnormalities (brain, carotid artery, 
heart, peripheral artery). 
 
Walking speed, grip strength, 
chair stand 
Participants with high microvascular and 
macrovascular burden had worse physical 
function, then those with low. WMH were 
independently associated with physical 
function. 
Rosario 2016 
USA  
(219) 
Health, Aging and Body 
Composition (Health 
ABC) study, N=265 
Mean 
82.9 
WMH Walking speed on the 
GaitMat II, an instrumented, 
computerized 8-m walkway 
WMH were more strongly associated with 
walking speed in those with low fractional 
anisotropy than those with high fractional 
anisotropy. 
De Laat 2010 
The Netherlands 
(226) 
 
The Radboud University 
Nijmegen Diffusion tensor 
and MRI Cohort 
(RUN DMC) study, N=431 
50-85 WMHs and lacunar infarcts GAITrite, Tinetti and Timed-
Up-and-Go test 
WMH and lacunar infarcts were associated with 
most gait parameters, with stride length as the 
most sensitive parameter related to WMH. 
Reviews: Zheng 2011 (153); Kilgour 2014 (157). 
WMH: white matter hyperintensities; PVS: perivascular spaces; CRF: cardiovascular risk factors; ARWMC: age-related white matter changes; SPPB: Short Physical Performance 
Battery; OLBS: one-leg balance stand; Cerebral microbleeds (CMBs). 
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